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Abstract 
ABSTRACT 
microRNAs (miRNAs) are ~22 nt long non-coding RNAs which are involved in post-
transcriptional gene regulation via mRNA silencing or degradation. miRNAs are abundant in 
the nervous system, where they have key roles in development and possibly in synaptic 
plasticity.  
Both RNA localization as well as stimulus-dependent local protein synthesis critically 
contribute to synaptic plasticity. During transport, the silencing of mRNAs within neuronal 
ribonucleoprotein particles (RNPs) can be achieved either by translational regulator-proteins 
or by miRNAs. Staufen2 (Stau2), an RNA-binding protein (RBP) investigated in the Kiebler 
lab, belongs to the family of dsRBPs and is mainly expressed in the nervous system. Staufen 
was shown to be involved in memory formation in Drosophila melanogaster. In hippocampal 
neurons, Staufen proteins are core components of distinct RNA-containing particles that 
reach out to distal dendrites.  
Recent evidence suggested a link between Stau2 and miRNAs. The export of Stau2 from the 
nucleus depends on Exportin-5, the main export factor for precursor-miRNAs. Therefore, this 
project aimed at investigating whether small non-coding RNAs, especially miRNAs, are part 
of Stau2-containing complexes in the rat brain. 
Immunoprecipitation, using affinity-purified anti-Stau2 antibodies, was performed to isolate 
Stau2 RNPs including all associated proteins and RNAs. On the protein level, the presence of 
different RISC-associated components like Ago, PACT, FMRP and eIF6 in Stau2 complexes 
suggested a participation of the miRNA pathway. 
On the RNA level, the specific association of small RNAs at the size of 20-22 nt with Stau2 
RNPs in E17 rat brain provided further evidence for a connection between miRNAs and Stau2 
complexes, as shown by radioactive labeling of RNA isolated after Stau2 
immunoprecipitation. In addition, RT-PCR proved the presence of 5 candidate miRNAs, 
miR-18, 26a, 128a, 134 and let-7c, in Stau2 complexes. In the future, RNA isolated from 
Stau2 immunoprecipitations will be cloned and sequenced to obtain a complete list of 
miRNAs associated with Stau2 complexes.  
A hypothesis to explain this association between miRNAs and Stau2 would be that the miRNA 
translationally silences its target mRNAs during transport in Stau2 complexes. Upon a specific 
stimulus, the suppression would be relieved allowing translation to occur at the synapse. 
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ZUSAMMENFASSUNG 
MikroRNAs (miRNAs) sind ~22 nt lange, nicht kodierende RNAs, welche Gene post-
transkriptionell regulieren können, indem sie die Translation hemmen oder den Abbau der 
mRNA auslösen. Im Nervensystem spielen miRNAs eine zentrale Rolle in der Entwicklung und 
wahrscheinlich auch bei der synaptischen Plastizität. 
Hierfür sind RNA-bindende Proteine (RBPs), welche mRNAs an die Synapsen lokalisieren, 
ebenso wichtig wie eine Stimulus-abhängige lokale Proteinsynthese. Während des Transports 
ist die Translation der mRNAs in neuronalen Ribonukleoprotein-Partikeln (RNPs) 
unterbunden, was entweder durch Regulator-Proteine oder durch miRNAs bewerkstelligt 
werden kann. Das im Kiebler Labor untersuchte Protein Staufen2 (Stau2) gehört zur Familie 
der dsRBPs und wird hauptsächlich im Nervensystem exprimiert. In der Taufliege Drosophila 
melanogaster spielt es eine Rolle bei der Gedächtnisbildung. In hippokampalen Neuronen 
stellen Staufen-Proteine wichtige Komponenten in RNA-enthaltenden Partikeln dar, welche 
sich bis in die distalen Dendriten erstrecken.  
Kürzlich wurde ein Zusammenhang zwischen Stau2 und miRNAs vorgeschlagen, da der 
Export von Stau2 aus dem Kern von Exportin-5 abhängig ist, dem primären Exportfaktor für 
Vorläufer-miRNAs. Deshalb war die Hauptaufgabe dieses Projekts zu untersuchen, ob kleine 
nicht-kodierende RNAs, im Besonderen miRNAs, in Stau2 Partikeln enthalten sind. 
Über Immunoprezipitationen mit affinitätsgereinigten Antikörpern gegen Stau2 gelang es, 
Stau2 RNPs mit allen enthaltenen Proteinen und RNAs zu isolieren. Auf Proteinebene wurden 
verschiedene RISC-assoziierte Komponenten wie Ago, PACT, FMRP und eIF6 in Stau2 
Komplexen gefunden, was auf eine Beteiligung von miRNAs hindeutet. 
Auf RNA-Ebene gelang mittels radioaktiver Markierung von RNA der Nachweis kleiner RNAs 
mit einer Größe von 20-22 nt in den Stau2 Komplexen. Dies ist ein weiterer Hinweis auf 
einen Zusammenhang zwischen miRNAs und Stau2 Partikeln. Zusätzlich wurde das 
Vorhandensein von miR-18, 26a, 128a, 134 und let-7c in Stau2 Komplexen mittels RT-PCR 
nachgewiesen. In Folge soll die in den Stau2 Immunoprezipitationen vorkommende RNA 
kloniert und sequenziert werden, um eine vollständige Liste aller Stau2-assoziierten miRNAs 
zu erhalten. 
Eine Hypothese um den Zusammenhang zwischen miRNAs und Stau2 zu erklären, wäre dass 
miRNAs eventuell eine Funktion in der Inhibierung der Translation von mRNAs in den Stau2 
Komplexen erfüllen. Während des Transports sind mRNAs in RNPs durch miRNAs gebunden, 
was die Translation verhindert. Dies wird später durch einen spezifischen Stimulus 
aufgehoben, welcher eine lokale Translation an der Synapse ermöglicht. 
Introduction 
1 INTRODUCTION 
1.1 SMALL RNAS 
In the 1990s, the first microRNAs (miRNAs), lin-4 and let-7, were discovered by genetic 
experiments in Caenorhabditis elegans (C. elegans). Since this time, extensive research took 
place in this field leading to the identification of the so-called short interfering RNAs 
(siRNAs), the effector molecules of RNA interference (RNAi) in plants, animals and fungi 
(reviewed in He and Hannon 2004; Grosshans and Filipowicz 2008). Up to now, different 
classes of small, non-coding regulatory RNAs were identified (reviewed in Grosshans and 
Filipowicz 2008; Filipowicz et al. 2005; Rana 2007). First, miRNAs, which are 20-25 
nucleotides (nt) in length, are encoded by specific genes and processed from single-stranded 
RNAs which are folded into hairpins. They can function via repression of translation or 
degradation of mRNAs. Second, siRNAs, which are 20-25 nt in length and formed by 
cleavage of long double-stranded RNAs (originally coming from viral infections). siRNAs are 
incorporated into the RNA-induced silencing complex (RISC) and capable of cleaving target 
mRNAs. Besides these two most prominent classes, there were also other groups identified, 
e.g. Piwi-associated RNAs (piRNAs) or repeat-associated small interfering RNA (rasiRNA). 
Still, the field of small RNAs is growing and new classes are likely to be identified. 
1.1.1 GENERATION OF MIRNAS AND SIRNAS 
The generation of miRNAs takes place in several steps, as shown in Figure 1.1 (reviewed in 
Filipowicz et al. 2008; Filipowicz et al. 2005). miRNAs are transcribed by Polymerase II from 
either independent miRNA genes or from introns of protein-coding genes. These primary 
transcripts (pri-miRNAs) are first processed by the Drosha/Pasha complex in the nucleus. 
Drosha belongs to the RNase III family, which are nuclear proteins of 130-160 kD in size, 
containing two RNase III catalytic domains and one double-stranded RNA-binding domain 
(dsRBD). Pasha, named DiGeorge syndrome critical region gene-8 (DGCR8) in mammals, is a 
dsRNA-binding protein (dsRBP) and like Drosha essential for the processing of pri-miRNAs to 
~70 nt long hairpins called precursor (pre)-miRNAs. These pre-miRNAs are transported from 
the nucleus to the cytoplasm via the Exportin-5 nuclear transport receptor complex in a Ran 
GTP-dependent manner.  
In a second cleavage step Dicer, another RNase III enzyme, is involved in the processing of 
the hairpins to yield a ~22 nt miRNA duplex. Dicer recognizes the 2 nt 3’ overhang from 
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pre-miRNAs generated by Drosha via the Piwi Argonaute Zwille (PAZ) domain. Cleavage by 
Dicer itself also leads to the generation of a 2 nt 3’ overhang. This cleavage step requires 
two other dsRBPs, Loquacious in Drosophila melanogaster (D. melanogaster) and human 
immunodeficiency virus (HIV-1) trans-activating response (TAR) RNA-binding protein (TRPB) 
in mammals. 
From the mature miRNA duplex, the strand with the 5’ terminus located at the 
thermodynamically less-stable end is selected to function as the mature miRNA, called the 
guide strand. This miRNA is assembled into miRNA-containing ribonucleoprotein particles 
(miRNPs) together with the Argonaute (Ago) proteins. The remaining strand of the duplex, 
the passenger strand, is degraded. 
 
 
Figure 1.1 - Biogenesis of miRNAs 
After transcription by PolII the pri-miRNAs 
are processed by the Drosha/DGCR8 
complex to yield pre-miRNAs. These 
~70 nt long hairpins are transported to the 
cytoplasm via the Exportin-5 export factor. 
Cleavage by Dicer, yielding a ~22 nt 
mature miRNA, involves the dsRBP TRPB in 
mammals. The guide strand from the 
mature miRNA duplex is assembled into 
miRNPs together with Argonaute proteins. 
Binding of miRNPs to target RNAs leads to 
either cleavage or translational repression, 
dependent on the mode of base-pairing.  
(from Filipowicz et al. 2008) 
 
The biogenesis of siRNAs is slightly different. In this case, the origin is a double-stranded 
RNA coming from a viral infection, anti-sense transcription or transfection. This dsRNA is 
cleaved by Dicer to yield a 22 nt siRNA duplex. Similarly, the guide strand gets incorporated 
into the RISC complex which is composed amongst others of Ago2 and Dicer (Filipowicz et 
al. 2005).  
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1.1.1.1 DIFFERENCES BETWEEN MIRNAS AND SIRNAS 
One main difference between siRNAs and miRNAs is their molecular origin. Another distinct 
feature is their mode of target recognition. In general, small RNAs recognize their target 
RNAs by sequence-specific base-pairing. The effect of the small RNA-mRNA interaction 
depends on the degree of complementarity between these two sequences. If the base-
pairing is nearly perfect, the target mRNA is cleaved in the middle of the siRNA/miRNA-
mRNA duplex. This is the case for siRNAs and most plant miRNAs (Jones-Rhoades et al. 
2006). In contrast, the base-pairing of animal miRNAs with mRNAs is imperfect, but still 
follows some rules. First, perfect base-pairing at the 5’ end in the seed region (miRNA 
nucleotides 2-8); second, the presence of a bulge or mismatches in the central region to 
exclude endonucleolytic cleavage and third, a reasonable complementarity at the miRNA 
3’ end to stabilize the interaction (Doench and Sharp 2004; Brennecke et al. 2005; Grimson 
et al. 2007). This imperfect base-pairing leads to either translational inhibition or degradation 
of the mRNA. 
1.1.2 RISC AND MIRNP ASSOCIATED PROTEINS 
After their generation, mature small RNAs are incorporated into the RISC (in case of siRNAs) 
or into miRNPs (in case of miRNAs). However, these two complexes share protein 
components and sometimes the term RISC is used for both, siRNAs and miRNAs. It is 
possible that a common core exists, which can associate with a variety of accessory proteins. 
The main components of the complexes containing siRNAs or miRNAs are Argonaute 
proteins, which are able to bind the 2 nt 3’ overhang of small RNAs via their PAZ domain. 
The Argonaute family consists of highly basic proteins of ~100 kD in size, containing PAZ 
and PIWI domains. They can be subdivided in PIWI and EIF2C/AGO proteins. In mammals, 
four Ago proteins exist (Ago1-4), which are expressed in various adult tissues including the 
nervous system. Ago2 is the only member having slicer activity and is therefore capable of 
cleaving siRNA/miRNA-mRNA duplexes (Meister et al. 2004). All four Ago proteins associate 
with miRNAs and are involved in translational repression. 
In addition to Ago family members, other proteins have been identified to associate with the 
RISC/miRNPs: Fragile-X mental retardation protein (FMRP), known as a translational inhibitor 
(Jin et al. 2004) and its Drosophila homologue Fragile-X-related protein (dFXR), vasa intronic 
gene (Caudy et al. 2002), tudor staphylococcal nuclease (Caudy et al. 2003), R2D2 (Liu et al. 
2003) as well as members of the Gemin family (Mourelatos et al. 2002). Further identified as 
RISC-associated proteins contributing to translational repression were armitage/MOV10, a 
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putative RNA helicase (Tomari et al. 2004) and RCK/p54, a DEAD-box helicase (Chu and 
Rana 2006). Depletion of either of them from mammalian cells impairs gene silencing by 
miRNAs. From two other RISC components, Dicer and TRBP, involved in production of 
miRNAs and siRNAs from precursor molecules, only TRBP contributes to RISC function 
(Haase et al. 2005). Finally, the eukaryotic initiation factor (eIF) 6 also accounts for 
translational repression and is discussed in detail later. 
1.1.3 FUNCTION OF MIRNAS 
1.1.3.1 TRANSLATIONAL REPRESSION AND MRNA DEGRADATION 
The exact mechanism by which miRNAs can down-regulate translation is currently under 
extensive investigation and the results obtained so far are controversial (reviewed in 
Filipowicz et al. 2008; Wu and Belasco 2008, pointed out in ). First studies 
involving sucrose density-gradient centrifugation revealed a shift of targeted mRNAs to 
translationally active polysomes of lower mass, meaning fewer ribosomes per message. This 
would suggest an inhibition at the initiation of translation (Pillai et al. 2005). Further studies 
showed that Ago has cap-binding ability and can therefore compete with eIF4E for binding 
the cap structure of the mRNA, resulting in inhibition of translation initiation (Kiriakidou et al. 
2007). Another mechanism proposed is the prevention of 60S ribosomal subunit joining 
(Chendrimada et al. 2007). It was reported, that eIF6 and 60S ribosomal subunits co-purify 
with the Ago-Dicer-TRPB complex. eIF6 was initially identified to interact with the 60S 
subunit and thereby preventing its interaction with the 40S subunit (Russell and Spremulli 
1978). The partial depletion of eIF6 in human cells and C. elegans rescued mRNA targets 
from miRNA inhibition. 
Figure 1.2
Other groups, however, have found no change in the polysome profile of targeted messages 
combined with the evidence that miRNAs can also repress cap-independent translation via an 
internal ribosomal entry site (IRES). These results rather suggest inhibition after initiation, at 
the elongation step (Maroney et al. 2006; Nottrott et al. 2006; Petersen et al. 2006). The 
inhibition could take place either through slowed elongation or ribosome ‘drop-off’. A third 
possibility displays the degradation of the nascent peptide (Nottrott et al. 2006). 
Independent of translational inhibition, deadenylation and subsequent degradation of miRNA 
targets was shown. Binding of the miRNPs can lead to the deadenylation of the mRNA by the 
deadenylase CCR4-NOT. This initiates the 5’ decapping by loss of poly(A)-binding proteins, 
exposing the message to exonucleolytic digestion from the 5’ end (Giraldez et al. 2006; Wu 
et al. 2006).  
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Figure 1.2 – Putative functions of miRNAs in the cell
miRNAs can repress translation either by inhibition at the initiation or elongation step, but can also 
cause proteolysis of the nascent peptide. Another effect of miRNPs is the degradation of the mRNA, 
triggered by deadenylation and decapping. (from Filipowicz et al. 2008) 
1.1.3.2 TRANSLATIONAL ACTIVATION 
Although miRNAs have long been thought to only down-regulate protein synthesis, new data 
indicate that they can also stimulate translation under certain conditions (Vasudevan and 
Steitz 2007; Vasudevan et al. 2007). Thus, a miRNA that inhibits translation in proliferating 
mammalian cells can have the opposite effect after cell-cycle arrest caused by serum 
starvation or treatment with the replication inhibitor aphidicolin. This effect depends on 
binding of the miR-369-3 to the 3’-untranslated region (UTR) of the target mRNA, in this 
case the tumor necrosis factor-α (TNFα) mRNA. The same serum starvation dependent up-
regulation was shown for targets of miRNA let-7 and the artificial miRNA cxcr4. The main 
protein involved is FXR1. Together with Ago2, it mediates the positive effect on translation of 
the targeted mRNA by miRNA-dependent binding to AU-rich elements (ARE) in the TNFα 
3’-UTR. Moreover, compared to Ago2, which can associate with target mRNAs under both 
conditions (repression and activation), FXR1 does so only in non-dividing cells. These 
findings lead to a very intriguing model that miRNPs and RBPs might act synergistically to 
either repress or activate mRNA translation. 
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1.1.3.3 RELIEF OF MIRNA-MEDIATED REPRESSION 
Another possibility for fine-tuning or regulating miRNA function is the relieve of miRNA-
mediated repression. Work by Bhattacharyya and others showed that in human hepatoma 
cells, cationic amino acid transporter 1 (CAT1) mRNA is translationally repressed by the liver-
specific miR-122 (Bhattacharyya et al. 2006). Upon stress, this repression is relieved by 
binding of the RBP HuR, to the 3’-UTR of CAT1 and subsequent re-entry of the mRNA into 
translating polysomes. HuR belongs to the family of embryonic lethal abnormal vision (ELAV) 
proteins, recognizes AU-rich elements and was implicated in modulation of mRNA translation 
and stability (Brennan and Steitz 2001). 
Recently, Kedde and colleagues provided evidence that the RBP Dead end (Dnd1) is able to 
block the interaction with miRNAs by binding target mRNAs and therefore relieves the 
repression (Kedde et al. 2007). Experiments in human teratoma cells showed that down-
regulation of endogenous Dnd1 reduces the expression of a reporter gene, depended on the 
presence of functional miRNA-binding sites. In zebrafish, Dnd1 counteracts the inhibition of 
nanos mRNA by miR-430. The group proposed a model, where Dnd1 binds to U-rich regions 
in the 3’-UTR and either physically blocks access of a miRNA to its binding site or changes 
the subcellular localization of the mRNA.  
Other examples for the relief of miRNA-mediated translational repression have been reported 
in neurons and are discussed later. 
1.1.4 MIRNAS IN THE NERVOUS SYSTEM 
The nervous system is a rich source of miRNAs with a diversity of functions that affect a 
large number of neuronal genes. To date, many miRNAs have been found to play a role in 
developmental processes (reviewed in Kosik 2006). For example, miRNAs are encoded within 
the Homeobox (Hox) gene cluster, which determines a distinct protein patterning along the 
anterior-posterior axis during Drosophila development (Pearson et al. 2005).  
Another process is the establishment and maintenance of cell identity: miRNA-124a and miR-
9 are implicated in the decision of mouse neuronal precursor cells to adopt either neuronal 
or glial fate and can shift the proportion of differentiating cells into the direction of neurons 
(Krichevsky et al. 2006). Also in the axonal path-finding, miRNAs were shown to have a 
function: In zebrafish, axon guidance abnormalities were associated with defects in Dicer 
function (Giraldez et al. 2005). Furthermore, functional RISC (composed of Ago3, Ago4, 
Dicer and FMRP) is present in developing axons of cultured rat neurons (Hengst et al. 2006). 
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1.1.4.1 DENDRITIC MIRNAS AND SYNAPTIC PLASTICITY 
Long-lasting memory formation requires new protein synthesis (Montarolo et al. 1986; Davis 
and Squire 1984). Furthermore, to date, an activity-dependent translation of several mRNAs 
has been shown in neurons (Aakalu et al. 2001). Therefore, based on the current knowledge 
about miRNA functions, it is very tempting to hypothesize a role of miRNAs in regulating 
local protein translation at the synapse. 
First support for this hypothesis came from the finding that miR-134 regulates the expression 
of LIM-domain kinase 1 (Limk1) mRNA at the synapse (Schratt et al. 2006). miR-134 is 
expressed in the hippocampus and in situ hybridization shows a punctate pattern in 
dendrites of cultured hippocampal neurons. Previously, Limk1 was reported to affect the 
spine structure by regulating actin filament dynamics through inhibition of the actin 
depolymerizing factor cofilin (Bamburg 1999). When Limk1 mRNA is translationally repressed 
by binding of miR-134 (at a single binding site), the dendritic spine size is negatively 
regulated. Upon synaptic stimulation by brain-derived neurotrophic factor (BDNF), the 
activated TrkB/mTOR signaling pathway relieves the miR-134-mediated repression and leads 
to enhanced Limk1 protein synthesis and spine growth. At the same time, miR-134 shifts to 
the polysome-associated pool of mRNAs (unpublished observation), suggesting that miR-134 
itself may not dissociated from the Limk1 mRNA to allow for its translation. BDNF could 
therefore alter the activity of some other translational regulators in this complex (Schratt et 
al. 2006). 
 
In an interesting related study, the expression of miR-132 was found to be regulated by 
BDNF, which functions through the activation of the transcription factor cAMP-response 
element binding protein (CREB) (Vo et al. 2005). A computational search predicted the 
GTPase-activating protein P250GAP, which regulates the Rho family, as a target of miR-132. 
Both miR-132 overexpression and knock-down of P250GAP expression induced neurite 
outgrowth in transfected rat primary cortical neurons, a phenocopy of the effects of ectopic 
CREB activity. Taken together, these observations indicate that CREB functions through the 
miR132-mediated silencing of P250GAP to promote neurite growth.  
Latest data show that RISC indeed acts at the synapse at least in D. melanogaster (Ashraf et 
al. 2006). Synaptic protein synthesis was measured using a fluorescent reporter of 
calcium/calmodulin-dependent protein kinase IIα (CaMKIIα). Thereby protein synthesis of 
CaMKIIα but also of Staufen (Stau) and Kinesin Heavy Chain (KHC) was found to be 
dependent on Armitage (named MOV10 in mammals), a protein required for RISC function. 
Proteasome-mediated degradation of Armitage upon external stimulation of olfactory 
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neurons in D. melanogaster led to the relief of suppression followed by CaMKIIα mRNA 
translation. The group concluded that degradative control of the RISC pathway underlies the 
pattern of synaptic protein synthesis associated with a stable memory. 
Taken together with the fact that many miRNAs are specifically expressed in the brain and 
three of the four mammalian ELAV proteins, HuB, HuC and HuD are restricted to neurons, it 
is likely that reversible miRNA-mediated regulation has an important role in brain 
development and function (Filipowicz et al. 2008). An overview how miRNAs regulate protein 
expression in neurons is shown in Figure 1.3. 
 
Figure 1.3 – miRNA-
mediated effects at the 
synapse 
Synaptic stimulation by 
glutamate or BDNF affects the 
translation of mRNAs in 
dendritic spines. Translational 
repression can take place in 
P-bodies, RNA granules or RBP 
platforms. Reactivation of 
translation might be controlled 
by the degradation of Armitage 
as well as release of mRNA 
cargo following synaptic 
stimulation. (from Kosik 2006)  
 
Linking the miRNA-mediated translation to synaptic stimulation leads to the following model: 
A miRNA-mRNA duplex (e.g. miR-134/Limk1 mRNA) can translocate from the so-called 
processing bodies (P-bodies), where translation is repressed, to polysomes. Other means of 
release of silenced mRNAs in dendrites include RNA granules, which can release their mRNA 
cargo following synaptic stimulation, or RBP-platforms, which are capable of carrying a suite 
of mRNAs (Kosik 2006). Reactivation of translation might be controlled by the degradation of 
Armitage. The stimulation of the ionotropic glutamate receptors (iGluR) by glutamate or of 
TrkB receptors by BDNF affects the translation of specific mRNAs in dendritic spines.  
An important question left is how miRNAs are transported to the dendrite. One possibility is 
that they hitch-hike on a target mRNA that contains dendritic localization signals. 
Alternatively, dendritic miRNAs might be processed from pre-miRNAs in the dendrite. This 
10 
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mechanism would require the independent transport of pre-miRNAs to the dendritic spines 
as well as the presence of RISC and Dicer at the synapse (reviewed in Kosik 2006). 
By combining laser-capture and multiplex real-time reverse transcription (RT) PCR, Kye and 
colleagues were able to quantify miRNAs in the neuritic and somatic compartment 
separately. Most neuronal miRNAs were detected in dendrites (Kye et al. 2007); for some 
miRNAs in situ hybridization was performed, showing a granular staining for miR-26a, 92, 
124a, let-7d. In the same study, the mRNA for the microtubule-associated protein 2 (MAP2) 
was validated as target mRNA for miR-26a. 
1.2 RNA GRANULES 
Different classes of RNA granules have been identified. They differ in their protein 
composition and function (Anderson and Kedersha 2006). Two of them, P-bodies and 
neuronal granules (e.g. transport RNPs) are discussed in more detail here. 
1.2.1 PROCESSING BODIES 
P-bodies contain components of the 5’-3’ mRNA decay machinery, of the nonsense-mediated 
decay (NMD) pathway and factors involved in miRNA-guided translational silencing 
(Anderson and Kedersha 2006). The core components are conserved from yeast to 
mammals, including the decapping enzyme complex DCP1–DCP2, the decapping activators 
RCK/p54, Pat1, RAP55 and EDC3 and the heptameric Lsm1–7 protein complex. P-bodies also 
contain other mRNA decay enzymes: the deadenylase complex CAF1–CCR4–NOT and the 
5’-3’ exonuclease XRN1. They lack ribosomes and all translation initiation factors with the 
exception of eIF4E (Filipowicz et al. 2008; Anderson and Kedersha 2006). 
P-bodies are considered as storage sites of translationally repressed mRNAs, including those 
repressed by miRNAs, as well as a place of mRNA degradation (Anderson and Kedersha 
2006). In general, these mRNAs are not associated with ribosomes. Indeed, ribosomes and 
P-bodies compete for mRNAs and repression of translation initiation may be sufficient to 
target mRNAs to P-bodies. Upon specific signals, such repressed mRNAs can even be 
released into the cytoplasm for further translation (Sossin and DesGroseillers 2006). 
Different hypotheses linking miRNA-mediated repression and P-bodies in mammals have 
been formulated (Wu and Belasco 2008). Either it is the ability of miRNAs to direct target 
messages to P-bodies what contributes to their effect on translational repression or, more 
likely, P-bodies represent a transient depot for silenced mRNAs until further use.  
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1.2.2 NEURONAL GRANULES 
Neuronal transport RNPs harbor translationally silenced mRNAs that are transported to 
dendritic synapses, where they are released and translated in response to specific exogenous 
stimuli. They consist of mRNAs, small and large ribosomal subunits, translation initiation 
factors and RBPs that regulate mRNA function. Despite the presence of intact ribosomes, it is 
important to note that translation is repressed in these structures until they arrive at the 
synapse, where translation may require an activating stimulus (Anderson and Kedersha 
2006).  
Different components have been identified in neuronal granules (reviewed in Kiebler and 
Bassell 2006; Sossin and DesGroseillers 2006). KIF5 motor protein, which is involved in their 
transport to the dendrites, several RNA-binding proteins such as Stau1 and 2, FMRP, 
ZIP-code binding protein 1 (ZBP1) and other trans-acting factors. The mechanism how 
mRNAs are silenced in RNA granules is still under intense investigation. One option is 
repression through RBPs: β-actin mRNA is silenced during transport via ZBP1, but also FMRP 
was shown to be involved in mRNA translational repression in vitro and in vivo (Hüttelmaier 
et al. 2005; Zalfa et al. 2006). Another possibility is silencing through miRNAs, e.g. Limk1 by 
miR-134 in mammals (see above) and CaMKIIα mRNA in D. melanogaster (Schratt et al. 
2006; Ashraf et al. 2006). 
1.2.2.1 THE STAUFEN FAMILY 
Staufen belongs to the family of dsRBPs, which contain three to five copies of the dsRBDs. In 
the Drosophila oocyte, Staufen plays an important role in localization of bicoid and oskar 
mRNAs to the anterior and posterior pole, respectively (reviewed in St Johnston 2005).  
In mammals, there are two Staufen genes that encode two distinct Staufen proteins, Stau1 
and Stau2 (Wickham et al. 1999; Duchaine et al. 2002). Stau1 is ubiquitously expressed 
whereas Stau2 is mainly present in the nervous system. Moreover, two isoforms for Stau1 
and four isoforms for Stau2 are generated through alternative splicing (Monshausen et al. 
2001; Duchaine et al. 2002). Both Staufen proteins are predominantly found in the 
cytoplasm around the perinuclear region and are associated with the endoplasmic reticulum. 
In hippocampal neurons, Staufen proteins additionally appear within distinct RNA-containing 
particles reaching up to the distal dendrites (Kiebler et al. 1999; Duchaine et al. 2002). 
Subsequent work showed, that Staufen-containing RNPs move along microtubules from the 
cell body into dendrites, suggesting a functional role of Staufen proteins in the dendritic 
localization of mRNAs (Köhrmann et al. 1999). 
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1.3 RNA LOCALIZATION IN NEURONS 
RNA localization is necessary in many different cell types and organisms during various 
biological processes. Neurons are highly polarized cells, containing long protrusions and 
forming a large number of synapses. Therefore, in the nervous system, the localization of 
RNAs plays an important role both during development (outgrowth and guidance of growth 
cones) and in the adult organism (for modification of synapses undergoing plasticity during 
learning).  
An important question is why localization of RNAs rather than of proteins to specific 
compartments is more advantageous to the cell. First, localization of RNAs and their local 
translation is believed to contribute to synapse-specific modifications. Other reasons are 
based on efficiency: local translation abolishes the need of regulating the activity of the 
proteins before they reach their target region. Furthermore, it makes it possible to regulate 
expression independently in different regions of the cell. Overall RNA transport provides 
additional spatial control and leads to a faster and more economical protein production 
(Dahm et al. 2007). 
 
Several steps are important in RNA localization, which are summarized in Figure 1.4. First, 
the RNA is processed in the nucleus. During this process, cis-acting sequence elements are 
recognized by RBPs, “labeling” the RNA for subsequent localization. Second, after the nuclear 
export other factors bind to obtain a fully competent cytoplasmic RNP. Third, the RNP 
associates with motors mediating its transport along microtubules. One example is ZBP2 
which associates with β-actin mRNA in the nucleus and facilitates its cytoplasmic localization. 
In the cytoplasm, β-actin mRNA RNPs are remodeled recruiting ZBP1 and then transported 
to neurites or growth cones (Gu et al. 2002; Zhang et al. 2001). During transport, mRNAs 
are translationally silenced. Fourth, following activation at the synapse, the protein is made 
by local translation and contributes to synaptic plasticity (Dahm et al. 2007). 
Localized RNAs contain cis-acting localization elements (LEs), recognized by RBPs. These LEs 
are generally present in the 3’-UTR. In the nervous system, LEs are found in e.g. the mRNAs 
for the immediate-early gene arg 3.1 (Arc) as well as β-actin, CaMKIIα, MAP2 and myelin 
basic protein (MBP). Also non-coding RNAs were found to be localized, e.g. brain cytoplasmic 
1 (BC1) RNA and miRNAs (reviewed in Dahm et al. 2007).  
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Figure 1.4 - RNA localization in mammalian neurons
After processing of the RNA in the nucleus it is recognized by RBPs and exported to the cytoplasm. A 
fully competent RNP is obtained upon binding of additional factors. This RNPs associate with motor 
proteins mediating their transport via microtubules. Important to note is that mRNAs are 
translationally silenced during transport. Synaptic activation leads to local translation, thereby 
contributing to synaptic plasticity. (from Dahm et al. 2007) 
1.4 AIM OF THE PROJECT 
Different studies indicate an involvement of Stau2 in the formation of long-term memory 
(Dubnau et al. 2003; Ashraf et al. 2006). Dubnau et al. reported an involvement of the 
pumilio/staufen pathway in Drosophila long-term memory (Dubnau et al. 2003). Based on a 
genetic screen, in vivo disruption of Staufen yielded defective memory. In the study by 
Ashraf and colleagues described in section 1.1.4.1, Drosophila Staufen protein was found to 
be subjected to miRNA-dependent regulation. Upon degradation of Armitage, a RISC-
associated factor, protein synthesis of Staufen increases, which may facilitate the synaptic 
transport of mRNAs (Ashraf et al. 2006). However, a detailed understanding of the function 
of Stau2 in mammals is still missing. 
The composition of Stau-containing particles in rat brain is currently investigated in the 
Kiebler lab (Mallardo et al. 2003; D. Karra and M. Kiebler, in preparation). Previously, it was 
shown that Stau2, if mutated in the RBD3, accumulated in the nucleolus in contrast to the 
14 
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prominent cytoplasmic localization of the wild-type protein (Macchi et al. 2004). 
Furthermore, Macchi and colleagues found that the export of Stau2 out of the nucleus is 
dependent on Exportin-5, which is the main export factor for pre-miRNAs. Exportin-5 was 
shown to interact in vitro with RBD3 of wild-type Stau2 in an RNA-dependent manner but 
not with mutated Stau2. Upon down-regulation of Exportin-5, the largest isoform (62 kD) of 
Stau2 accumulates in the nucleolus (Macchi et al. 2004). Stau2 was shown to bind dsRNA in 
a sequence independent manner but rather interacts with stem-loops containing 12 
uninterrupted base pairs in vitro (Ramos et al. 2000). Since pre-miRNAs are folded into 
hairpin structures, this work suggested for the first time a possible link between Stau2 and 
the generation of miRNAs.  
In the Drosophila oocyte, Staufen plays an important role in localization of bicoid and oskar 
mRNAs (St Johnston 2005). In addition, an involvement of Stau in translational activation of 
oskar mRNA in D. melanogaster was also shown (Micklem et al. 2000). However, the exact 
function of Stau2 in mammals remains to be investigated.  
As described in section 1.3, localized mRNAs are thought to be silenced during transport. 
This could be achieved either by proteins and/or by miRNAs. The only evidence for functional 
dendritic miRNAs to date, is the regulation of Limk1 by miR-134 at the synapse, which was 
shown to have an effect on spine growth. Based on these findings, it was of great interest 
for my project to investigate whether small non-coding RNAs (especially miRNAs) are part of 
Stau2-containing complexes in rat brains.  
Furthermore, by combining data from the mRNA composition of Stau2 particles (A. Konecna 
and M. Kiebler, unpublished) with data on small RNAs, new pairs of mRNA-miRNA are 
expected to be identified. This could then lead to a detailed understanding of miRNA-
mediated silencing of mRNAs during transport with regards to how many and which mRNAs 
are regulated by miRNAs. 
 
Materials and methods 
2 MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 REAGENTS AND CONSUMABLES  
Reagents 
Acrylamide mix, 30% Roth 
Acetic acid Roth 
Acetone Roth 
Adenosine triphosphate (ATP) Fluka 
Agar  Sigma 
Agarose  Roth 
Ammonium peroxodisulfate (APS)  Roth 
Ampicillin Roth 
β-Mercaptoethanol Sigma 
Bovine serum albumin (BSA) Serva 
Bromphenol blue  Serva 
Coomassie Brilliant blue Merck 
Deoxycholate (DOC) Sigma 
DetectorTM Block  KPL 
Dialysis membrane MWCO 6-8000 SpectraPor 
Diethyl pyrocarbonate (DEPC) Sigma 
Dimethylpimelimidate dihydrochloride (DMP) Sigma 
DL-Dithiothreitol (DTT) Sigma 
Ethanol, absolute Roth 
Ethanol, technical Roth 
Ethanolamine Sigma 
Ethidium bromide Fluka 
Ethylenediaminetetraacetic acid (EDTA), disodium salt Sigma 
Filter, 0.45 μm Schleicher & Schuell 
Filter, Steritop 0.2 µm Millipore 
Formaldehyde, 37% Roth 
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GeneRulerTM 1 kb DNA Ladder (0.5 µg/µl) Fermentas 
GeneRulerTM 100 bp DNA Ladder (0.5 µg/µl) Fermentas 
Glutardialdehyde Roth 
Glutathione SepharoseTM 4 Fast Flow (GSFF) GE 
L-Glutathione, reduced  Sigma 
Glycerol Sigma 
Glycine Merck 
2-[4-(2-Hydroxyethyl)-1-piperazinyl-ethanesulfonic acid (HEPES) Sigma 
Hydrochloric acid, 37% Roth 
Isopropanol (2-Propanol) Roth 
Isopropylthiogalactoside (IPTG) Roth 
Leupeptin Serva 
Loading Dye Solution, 6x Fermentas 
MagneGST Glutathione particles Promega 
Magnesium chloride Fluka 
Methanol, technical Roth 
Methanol Roth 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) Roth 
Nitrocellulose membrane, 0.22 µm Schleicher & Schuell 
NonidetTM P 40 Substitute (NP-40) Sigma 
O'GeneRulerTM DNA Ladder, low range (0.1 µg/µl) Fermentas 
Orange Loading Dye Solution, 6x Fermentas 
PageRulerTM Prestained Protein Ladder Fermentas 
PBS Dulbecco, w/o Ca2+ Mg2+ Biochrom 
Pefabloc (AEBSF) Roche 
Pepstatin Roche 
Ponceau S Merck 
Potassium acetate Merck 
Potassium chloride Sigma 
Precision Plus ProteinTM All Blue Standard Bio-Rad 
Protease inhibitor cocktail tablets, EDTA free Roche 
Protein A Sepharose (from Staph. aureus) Sigma 
Protein Assay Dye Reagent Concentrate  Bio-Rad 
RiboLock Ribonuclease Inhibitor 40 u/µl Fermentas 
Ribonuclease A Sigma 
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RNase A + T mix  Fermentas 
Sephacryl S300-High Resolution Amersham Pharmacia 
Silver nitrate Merck 
Sodium acetate Merck 
Sodium azide Roth 
Sodium chloride Merck 
Sodium dodecylsulfate (SDS) Serva 
Sodium hydroxide Merck 
Sucrose Sigma 
SYBR® GOLD nucleic acid stain Invitrogen 
Trichloric acid (TCA) Merck 
Tris(hydroxymethyl)aminomethane (Tris) Roth 
Triton X-100 Roth 
Trizma hydrochloride Sigma 
Tryptone Roth 
Tween 20 Roth 
Vivaspin Concentrator (10 kD MWCO)  Vivascience 
Vivaspin Concentrator (50 kD MWCO)  Vivascience 
Whatman chromatography paper Multimed 
Yeast extract Roth 
Yeast tRNAs Roche 
 
RNA grade reagents 
Acid Phenol:Chloroform, MB grade Ambion 
Acrylamide/Bis (19:1), 40% Ambion 
Ammonium peroxodisulfate (APS) Roth 
Cytidine 3',5'-bis [α-32P] phosphate (pCp) 
                    (10 mCi/ml; 3000 Ci/mmol) GE 
Dimethyl sulfoxide (DMSO) Sigma 
Formaldehyde, 37% Merck 
Formamide (deionized) Ambion 
Gel loading buffer II  Ambion 
Glycogen, RNA grade (20 mg/ml) Fermentas 
Magnesium chloride for molecular biology, 1 M Sigma 
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MicroSpin G-25 columns GE 
Morpholinopropane sulfonic acid (MOPS) Serva 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) Roth 
Non-stick RNase free tubes Ambion 
Imaging Screen K, 20x25 cm Biorad 
2-Propananol, for molecular biology, min 99% Sigma 
RNase ZAP Sigma 
Sodium acetate pH 5.5, 3 M Ambion 
Sodium chloride for molecular biology, 5 M Sigma 
Sodium dodecyl sulfate (SDS) 10% Sigma 
10x TBE electrophoresis buffer Fermentas 
Top Vision LE GQ Agarose Fermentas 
Trizma hydrochloride solution Sigma 
Urea Ambion 
Water, DNase + RNase free Sigma 
 
Kits 
Molecular Weight marker kit, for GF chromatography, Sigma 
GenEluteTM Plasmid MiniPrep Kit, Sigma 
QIAquick Gel Extraction Kit, Qiagen 
2x Rapid Ligation Kit, Promega 
QIAquick PCR purification Kit, Qiagen 
mirVanaTM miRNA Isolation Kit, Ambion 
mirVanaTM qRT-PCR miRNA Detection Kit, Ambion 
2.1.2 ENZYMES 
DNase I    Boehringer Mannheim 
Lysozyme     Sigma 
BamHI (10 u/µl) + buffer  Fermentas 
EcoRV (20 u/µl) + buffer/BSA NEB 
NotI (10 u/µl) + buffer  Fermentas 
SalI (10 u/µl) + buffer  Fermentas 
T4 RNA Ligase (10 u/µl)  Fermentas 
T4 DNA Ligase (3 u/µl)  Promega 
Taq DNA polymerase (5 u/µl) Fermentas 
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2.1.3 ANTIBODIES 
Rabbit anti-Stau2FL (rabbit H7) 1:1000 (WB) 
Antigen: His-Stau2FL 
Generated by Dipl.-Biol. Daniela Karra (Kiebler Lab), see D. Karra, 2008, PhD thesis 
 
Rabbit anti-Stau2CT (rabbit R) 1:1000 (WB) 
Antigen: GST-Stau2CT 
Generated by Dr. Anke Deitinghoff (Kiebler Lab) 
 
Primary antibodies for Western blotting 
 
Ag size (kD) species dilution company 
Upf1 130 goat 1:500 Abcam 
Ago2 95 Mab 1:250 Abnova 
PACT 36 rabbit 1:1000 Dr. G. Meister 
eIF6 26 Mab 1:1000 BD Transduction Labs 
FMRP 70 – triple band mouse 1:500 Chemicon 
eEF1a 53 Mab 1:1000 Biomedica 
eIF4E 25 Mab 1:1000 BD Transduction Labs 
S6 32 Mab 1:500 Cell signaling 
L7a 34 rabbit 1:5000 Prof. Dr. A. Ziemiecki 
2.1.4 PLASMIDS AND PRIMERS 
pGEX vectors (GST Gene Fusion System): pGEX-4T-2 and pGEX-6P-1, GE Healthcare 
resistance: ampicillin 
pGEX-4T-2 containing Stau2CT (Thr 379 until stop 512), inserted at NotI/SalI sites 
resistance: ampicillin 
from Dr. L. DesGroseiller, University of Montreal, Canada 
GST-3C (PreScission protease):  
containing N-terminally GST-tagged 3C (PreScission) protease  
resistance: ampicillin 
from Andi Geerlof at the EMBL outstation in Hamburg 
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Primers for RT-PCR (Ambion) 
hsa-miR-18 (AM 30065) 
hsa-miR-26a (AM 30123) 
hsa-miR-128a (AM 30026) 
hsa-miR-134 (AM 30034) 
hsa-let-7c (AM 30002) 
2.1.5 ANIMALS 
Animals were obtained from the Medical University Vienna, Core Unit of Biomedical 
Research, Division of Laboratory Animal Science and Genetics, Himberg  
 
Rats (Rattus norvegicus domesticus) Strain: Him:OFA Sprague-Dawley (SD) 
Adult: 9-11 weeks old, pregnant female rats 
E17: embryos (E17) from adult rats (brains used for biochemistry were missing the 
hippocampi) 
Brains were removed by Sabine Thomas, John Vessey, Julia Riefler and Krzysztof 
Wieczorek 
Rabbits, mast hybrids, New Zealand White Basis 
used for antibody production 
2.1.6 CELLS 
BL21 (DE3) pLysS: F-, ompT hsdSB (rB- rB-) gal dcm (DE3); pLysS (camr), Invitrogen 
TOP 10, F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araleu) 
7697 galU galK rpsL (Strr) endA1 nupG, Invitrogen 
2.1.7 BUFFERS AND SOLUTIONS 
Molecularbiology and cloning 
50x TAE (2 l)    484 g Tris base 
     114.2 ml acetic acid 
     200 ml EDTA (0.5 M, pH 8.0) 
     Adjust pH to 7.5 - 7.8 
 
1x TAE     dilute from 50x TAE 
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Expression and purification of proteins 
2x YT (for 200 ml)   3.2 g tryptone 
     2 g yeast extract 
1 g NaCl  
     Autoclave 
 
LB (for 1 l)    10 g tryptone 
     5 g yeast extract 
10 g NaCl  
     Autoclave 
 
PBS Dulbecco, w/o Ca2+ Mg2+  140 mM NaCl 
2.7 mM KCl 
16 mM disodium hydrogen phosphate 
1.8 mM potassium dihydrogen phosphate 
Adjust pH to 7.1 with HCl 
 
PreScission protease 
Lysis Buffer    50 mM TrisHCl, pH 8.0 
200 mM NaCl 
1 mM DTT 
1 ST Lysozyme and DNase I 
 
Wash Buffer    50 mM TrisHCl, pH 8.0 
     300 mM NaCl 
     1 mM DTT 
 
Elution Buffer     50 mM TrisHCl, pH 8.0 
     200 mM NaCl 
     1 mM DTT 
     10 mM L-glutathione reduced 
 
Dialysis Buffer    50 mM TrisHCl 
     200 mM NaCl 
     1 mM DTT 
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     10 mM EDTA 
     20% glycerol 
adjust pH to 8.0 
 
Stau2 proteins 
Lysis Buffer    50 mM Tris pH 7.5 
500 mM NaCl 
0,1% TritonX-100 – add after resuspension of the cells 
2 mM DTT 
8% glycerol  
Lysozyme 1 mg/ml final 
Protease inhibitors: Pefablock, Leustatin, Pepstatin; 1x 
 
ATP/MgCl2 buffer    10 mM ATP 
10 mM MgCl2 in water 
 
Dialysis Buffer (GST-Stau2CT) PBS 
 
Dialysis Buffer (Stau2CT)  PBS + 8% glycerol 
 
Buffer A     50 mM Tris pH 7.5 
8% glycerol  
 
Buffer B    Buffer A + 20 mM glutathione, set pH to 8 
 
Cleavage Buffer   50 mM TrisHCl, pH 7.0 
     150 mM NaCl 
     1 mM DTT 
     1 mM EDTA 
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Analysis of proteins 
Minigels, 0.75 mm: 
 Separation gel (5 ml/gel)  Stacking gel (2 ml/ gel) 
 10% [ml] 12% [ml]   4% [ml] 
H2O 1.9 1.6  H2O 1.4  
30% acrylamide 1.7 2.0  30% acrylamide 0.33 
1.5 M Tris pH 8.8 1.3 1.3  1 M Tris pH 6.8 0.25 
10% SDS 0.05 0.05  10% SDS 0.02 
 Mix well   Mix well 
10% APS 0.05 0.05  10% APS 0.02 
TEMED 0.002 0.002  TEMED 0.002 
 
6× Laemmli-buffer (SDS-PAGE): 10% SDS 
350 mM TrisHCl pH 6.8 
30% glycerol 
0.1% Bromphenol blue 
600 mM DTT 
 
10x SDS running buffer  0.25 M Tris 
1.92 M glycine 
1% SDS 
 
Coomassie staining solution   0.1% Coomassie Brilliant Blue 
40% methanol 
10% acetic acid 
 
Coomassie destaining solution 40% methanol 
10% acetic acid 
 
Fixation solution (silver)  15 ml ethanol 
     5 ml acetic acid 
     Up to 50 ml water 
 
Reducing and crosslinking (silver) 15 ml ethanol 
     3.4 g sodium acetate 
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0.1 g sodium thiosulfate (5x H2O) 
0.25 ml glutaraldehyde (25%) 
Up to 50 ml water 
 
Silver incubation   0.1 g silver nitrate 
10 µl formaldehyde 
Up to 50 ml water 
 
Developing solution (silver)  2.5 g sodium carbonate 
     10 µl formaldehyde 
     Up to 100 ml water 
 
10× Blotting buffer (Towbin)  250 mM Tris 
1.92 M glycine 
 
1× Blotting buffer   10% 10× blotting buffer 
20% methanol 
70% H2O 
 
Ponceau-S solution    0.2% Ponceau S 
3% TCA in water 
 
10× TBS     150 mM Tris  
1.5 M NaCl 
Set pH to 7.5 
 
TBS-T     1x TBS with 0.1% (v/v) Tween 20 
 
Blocking solution   0.2 g Detector Block powder 
(1x DetectorTM Block)   20 ml 5x Detector Block solution 
     80 ml water 
 
Gel filtration 
GF buffer    50 mM HEPES  
150 mM KCl 
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pH 7.3, 0.22 µm filtered 
 
Homogenization solution (HS) 10 mM HEPES pH 7.5  
320 mM sucrose  
1 tablet of protease inhibitor cocktail, Roche 
2 µl RiboLock/ml  
 
Immunoprecipitation 
Tris buffer (for affinity purification) 250 mM NaCl 
     25 mM TrisHCl pH 8.5 
 
4x BEB (brain extraction buffer) 100 mM HEPES pH 7.3 
     600 mM KCl  
32% glycerol  
0.4% NP-40  
 
RNA methods 
DEPC water  ddH2O including 0.1% of DEPC was constantly stirred for 
6 h and subsequently autoclaved 
 
10x TBE electrophoresis buffer 
Diluted to 1x TBE    89 mM Tris 
89 mM boric acid 
2 mM EDTA 
 
10x MOPS:     0.4 M MOPS 
0.1 M NaAc (3x H2O) 
10 mM EDTA 
adjust to pH 7.2 with NaOH 
 
RNA loading dye mix   50% glycerol 
     10 mM EDTA 
     0.25% Bromphenol blue 
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2.1.8 EQUIPMENT 
Thermomixer compact, Eppendorf 
Vortex VF2 Janke & Kunkel IKA 
pH Meter MP 225, Mettler Toledo 
Shaker, GFL 3015 
Waterbath, GFL 
Incubator, shaking, INFORS, Unitron 
Incubator, kelvitron t, Heraeus 
Balance, KERN ABS 
Balance, KERN 440-49N 
GeneQuant Pro spectrophotometer, Amersham Pharmacia 
 Cuvette Suprasil, 10 mm, Hellma 
Potter homogenizer, 557, 5ml, B.Braun, Melsungen 
Ultrasound processor, UP 400s, dr. hielsche GmbH 
BioLogic LP system and BioLogic BioFrac fraction collector 
FPLC LCC-500, Pharmacia and Fraction collector Frac-200, Pharmacia LKB 
Power Pac 300 power supply for electrophoresis, BIO-RAD 
Power Pac HC power supply for electrophoresis, BIO-RAD 
Mini-Protean® 3 Cell SDS-PAGE-System, BIO-RAD 
Trans-Blot Cell blotting chamber, BIO-RAD 
Infrared Imager Odyssey Li-Cor Biosciences 
PCR-machine, PTC-200 Peltier Thermal Cycler, MJ Research 
Peqlab imaging system with UV/IR interference filter type F590 or SYBR® photographic filter 
Centrifuge 5417 C Eppendorf 
Centrifuge 5417 R Eppendorf  
Virifuge 3.OR Heraeus 
 Rotor Heraeus #8074 
Centrifuge AvantiTM J-25, Beckman Coulter 
 Rotor JLA 10.500, Beckman 
 Rotor JA 25.50, Beckman 
Ultracentrifuge OptimaTM TXL, 120000 rpm, Beckman 
Rotor TLA 100.3, Beckman with polycarbonate centrifuge tubes, 13x51 cm, Beckman 
Molecular Imager® FX (+ Screen Eraser – K), BioRad 
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2.2 METHODS 
2.2.1 MOLECULAR BIOLOGY  
2.2.1.1 PREPARATION OF PLASMID DNA 
Plasmid DNA (pDNA) was prepared using the GenEluteTM Plasmid MiniPrep Kit from Sigma. 
Four ml of the o/n culture were used to pellet bacteria at 14,000 rpm for 5 min, 4°C. Lysis of 
the cells and pDNA purification was carried out as stated in the manufacturer’s protocol. The 
elution of pDNA was performed in 50 - 70 µl ddH2O, whereby the yield was increased by 
performing an incubation step in ddH2O for 1 min before the final centrifugation. As a last 
step, DNA concentration was measured in a 1:20 dilution at 260 nm. 
2.2.1.2 PREPARATION OF COMPETENT BL21 CELLS AND TRANSFORMATION 
For o/n cultures, 5 ml of LB were inoculated with BL21 cells and grown at 37°C. The next 
day, 200 µl of the o/n culture were used to inoculate 10 ml of LB which was subsequently 
grown at 37°C until an OD600 ~0.5. The cell suspension was chilled on ice for 10 min and 
centrifuged at 1,700 g for 8 min at 4°C. The pellet was resuspended in 10 ml of cold 0.1 M 
CaCl2, which was prepared freshly and filter sterilized. After incubation on ice for 30 min, 
cells were pelleted again at 1,700 g for 8 min at 4°C, resuspended in 2 ml cold 0.1 M CaCl2 
and incubated for another 2 h on ice. The competent cells were distributed into 200 µl 
aliquots, frozen on dry ice and stored at -80°C. 
 
Transformation 
Competent cells were thawed on ice and mixed with 10 µl of ligation mix or 10 ng (1 µl) of 
pDNA. After incubation on ice for 30 min, a heat shock was performed at 42°C for 1 min. 
Afterwards, cells were chilled on ice for 2 min before incubation with 1 ml of LB at 37°C for 
1 h shaking. In case of transforming a ligation mix, cells were pelleted at 950 g for 3 min, 
resuspended in 100 µl LB medium and plated on LB plates containing the appropriate 
antibiotics. For pDNA transformation, only 50 – 100 µl of the cell suspension were plated in 
the same way. Incubation was performed o/n at 37°C. 
2.2.1.3 AGAROSE GEL ELECTROPHORESIS 
Gels were prepared by dissolving the appropriate amount of agarose in 1x TAE. After cooling 
down the mixture by constant stirring, 20 µl of ethidium bromide (0.2 mg/ml) were added 
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per 100 ml of agarose solution. After pouring the gel, it was allowed to polymerize at RT. 
Samples were prepared by combining them with 6x LD and loaded onto the gel in 
combination with a suitable marker. Separation of DNA was performed in 1x TAE at 100 V 
constant. 
2.2.2 CLONING OF GST-STAU2CT INTO PGEX-6P-2 
2.2.2.1 CLONING OF PGEX-6P-2 
The pGEX-6P-2 vector was constructed from pGEX-6P-1 and pGEX-4T-2. The purpose was to 
combine the MCS of pGEX-4T-2 with the PreScission cleavage site from pGEX-6P-1, which 
yields pGEX-6P-2. The coding region for GST including the thrombin cleavage site was 
excised from pGEX-4T-2 with BamHI and EcoRV and replaced by the coding region for GST 
containing the PreScission cleavage site from pGEX-6P-1. Two successive restriction 
digestions were performed as follows.  
 
1st restriction 50 µl  1st restriction 50 µl 
PGEX-4T-2 pDNA 40 µl = 6.2 µg  PGEX-6P-1 pDNA 44 µl = 7.0 µg
ddH2O 4 µl  10x buffer BamHI 5 µl 
10x buffer BamHI 5 µl  BamHI 10 u (1 µl) 
BamHI 10 u (1 µl)    
 
In general, restriction digestions were incubated at 37°C for 1.5 h, then 0.5 µl fresh enzyme 
was added and incubated for another 45 min at 37°C. The restriction digestion was purified 
from the previous buffer using the QiaQuick PCR purification kit. The pDNA was finally eluted 
in 46 µl ddH2O, 3 µl were saved for test purposes and the resulting 43 µl were subjected to a 
second round of restriction digestion. 
 
2nd restriction 50 µl  2nd restriction 50 µl 
PGEX-4T-2 pDNA 
(BamHI cleaved) 
43 µl   PGEX-6P-1 pDNA 
(BamHI cleaved) 
43 µl  
10x buffer NEB3 5 µl  10x buffer NEB3 5 µl 
100x BSA 0.5 µl  100x BSA 0.5 µl 
EcoRV 20 u (1 µl)  EcoRV 20 u (1 µl) 
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Restriction digestions were performed as before. The restriction digestion (50 µl) was 
separated by 1% agarose gel electrophoresis. The fragments for pGEX-4T-2 (3187 bp) as 
well as for pGEX-6P-1 (1798 bp) were excised from the gel and eluted using the QIAquick 
Gel Extraction Kit according to the manual. The final elution volume was 30 µl of ddH2O. For 
constructing the new pGEX-6P-2 the two fragments were ligated in the following way: 
 
 
 
ligation 10 µl 
pGEX-4T-2 (BamHI, 
EcoRV cleaved) 
2 µl  
pGEX-6P-1 (BamHI, 
EcoRV cleaved) 
2 µl  
2x ligation buffer 5 µl 
T4 DNA Ligase 3 u (1 µl) 
The ligation was performed for 1 h at RT and the whole ligation mixture was transformed 
into 100 µl TOP 10 competent cells. Seven colonies were randomly picked, grown o/n in 4 ml 
of LB amp and used for pDNA preparation. In order to find positive clones, a restriction 
digestion was performed as follows: 
 
test restriction 15 µl 
PGEX-6P-2 pDNA 8 µl  
10x buffer O 1.5 µl 
ddH2O 5 µl 
Sal I 5 u (0.5 µl) 
 
Restriction digestion was performed at 37°C for 2 h and analyzed by 1% agarose gel 
electrophoresis. The size of the linearized plasmids was compared to SalI digested 
pGEX-6P-1 vector to check for positive clones. For further cloning one of the positive clones 
was used. 
2.2.2.2 CLONING OF STAU2CT INTO PGEX-6P-2 
The sequence corresponding to the C-terminal part of the mouse Staufen 2 protein (Thr 379 
– stop 512) from pGEX-4T-2 (Duchaine et al. 2002) was cloned into pGEX-6P-2 using 
NotI/SalI restriction sites. Restriction digestions were performed as follows: 
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restriction 50 µl  restriction 50 µl 
Stau2CT in pGEX-4T-2 43 µl = 8.4 µg  pGEX-6P-2  40 µl  
10x buffer O 5 µl  ddH2O 3 µl 
NotI 10 u (1 µl)  10x buffer O 5 µl 
SalI 10 u (1 µl)  NotI 10 u (1 µl) 
   SalI 10 u (1 µl) 
 
The restriction digestions (50 µl) were separated by 1% agarose gel electrophoresis. The 
fragments of pGEX-6P-2 (4985 bp) and Stau2CT (734 bp) were excised from the gel and 
eluted using the QIAquick Gel Extraction Kit according to the manual. The final elution 
volume was 30 µl of ddH2O. The two fragments were ligated in the following reaction: 
 
ligation 10 µl 
pGEX-6P-2  
(NotI, SalI cleaved) 
3 µl  
Stau2CT  
(NotI, SalI cleaved) 
1 µl  
2x ligation buffer 5 µl 
T4 DNA Ligase  3 u (1 µl) 
 
Ligation was performed for 1 h at RT, afterwards 10 µl ligation mix were transformed into 
100 µl TOP 10 competent cells. Eight colonies were randomly picked, grown o/n in 4 ml of 
LB amp and used for pDNA preparation. In order to find positive clones which contain the 
correct insert, a restriction digestion was performed as follows: 
 
test restriction 15 µl 
Stau2CT in pGEX-6P-2 8 µl  
10x buffer O 1.5 µl 
ddH2O 4.5 µl 
SalI 5 u (0.5 µl) 
NotI 5 u (0.5 µl) 
 
Restriction digestion was performed at 37°C for 2 h and analyzed by 1% agarose gel 
electrophoresis together with pGEX-6P-2 as a size control to check for positive clones. For 
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protein expression, the obtained mStau2CT construct in pGEX-6P-2 was transformed into 
200 µl BL21 competent cells and plated on LB amp plates o/n at 37°C. 
2.2.3 EXPRESSION AND PURIFICATION OF PROTEINS 
2.2.3.1 PURIFICATION OF GST-PRESCISSION PROTEASE 
The protocol was developed by Andi Geerlof at the EMBL outstation in Hamburg. 
 
Expression 
For the expression of the GST-tagged PreScission protease, two o/n cultures were prepared 
by inoculating 4 ml of LB amp (0.1 mg/ml) with one colony of pGEX-3C in BL21 and 
incubating o/n at 37°C. The next morning, cells of the o/n cultures were collected, 
resuspended in 1 ml fresh LB medium and used for inoculation of 2 times 500 ml LB 
including 0.5% glucose and 0.1 mg/ml amp. Cells were grown at 37°C until OD600 of ~0.6. 
Cells were chilled on ice for 3 min, induced subsequently with 0.2 mM IPTG and allowed to 
express the recombinant protein o/n at 20°C. Cells were harvested at 3000 g (4,000 rpm, 
rotor JLA 10.500) for 15 min at 4°C and stored at –20°C until further use. 
 
Purification 
Cells were thawed and resuspended in 20 ml lysis buffer for each 500 ml expression culture. 
Both suspensions were pooled and subjected to lysis together. A spatula tip of DNase I and 
of lysozyme was added to the suspension as well as 2 ml of 4 mg/ml Pefabloc protease 
inhibitor. To break the cells, they were sonicated 8 times for 10 sec (output 7, 100% cycle) 
on ice and subsequently subjected to 2 freeze/thaw cycles. Cell debris and unbroken cells 
were first removed by centrifuging the cell lysate for 10 min at 15 000 g (13,500 rpm, 
JA 25.50 rotor) at 4°C. Afterwards, the lysate supernatant was prepared by a second 
centrifugation for 1 h at 50,000 g (25,000 rpm, JA 25.50 rotor) at 4°C. Five ml of GSFF were 
packed in a column and equilibrated with wash buffer at 0.5 ml/min using the BioLogic 
purification system. The lysate supernatant (35 ml) was loaded onto the column at a flow 
rate of 0.25 ml/min. Unspecifically bound proteins were washed off with wash buffer at 
0.5 ml/min until the baseline was reached as monitored by the absorbance at 280 nm. The 
peak fractions were pooled and dialyzed o/n against 2 l of dialysis buffer at 4°C. After 
measuring the concentration, the purified protease was aliquoted into fractions of 0.5 ml and 
stored at –80°C. 
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Protein concentration determination 
The amount of the PreScission protease was determined by measuring the absorbance at 
280 nm of the protein solution after dialysis. The concentration was calculated using a 
specific extinction coefficient of 1.005 (i.e. a protease solution of 1 mg/ml gives an A280 of 
1.005). The predicted molecular weight of GST-3C is 46.4 kDa.  
The concentration of the PreScission protease was determined to be 7.36 mg/ml. The 
activity can be roughly estimated - based on the specific activity of highly purified protease 
using this protocol – with 1000 U/mg. Therefore, it was assumed that the protease 
preparation had an activity of 7,360 U/ml.  
 
Preparation of samples for SDS-PAGE 
In general, samples for SDS-PAGE to monitor the purification process were prepared from 
total lysate, supernatant, flow-through (FT) and washing steps by diluting 1:1 (5 µl sample + 
5 µl PBS) as well as from the eluate (2 µl and 10 µl). 
2.2.3.2 EXPRESSION OF GST-STAU2CT  
For the expression, o/n cultures were inoculated with one colony of BL21 containing 
GST-Stau2CT in pGEX-6P-2 as described in section 2.2.3.1. The next morning, 400 ml of 
2x YT amp (0.1 mg/ml) were inoculated with 4 ml of the o/n culture and grown at 37°C until 
OD600 of ~0.6. Cells were chilled on ice for 3 min and subsequently induced with 0.1 mM 
IPTG. Cultures were incubated 3 h at 25°C and harvested at 3,000 g (4,000 rpm, rotor JLA 
10.500) for 15 min at 4°C. The cells were then stored at –20°C until further use or subjected 
to purification immediately.  
2.2.3.3 PURIFICATION STAU2CT 
Cells were thawed (if frozen), resuspended in 40 ml of lysis buffer and incubated 20 min at 
RT in the presence of lysozyme (1 mg/ml) and 0.1% Triton X-100. To lyse the cells, they 
were subjected to freeze/thaw-cycles for 2-3 times. To break the DNA completely a spatula 
tip of DNase I was added and an incubation step took place for additional 10 min at RT. Cell 
debris and unbroken cells were removed by centrifuging the cell lysate for 30 min at 
20,000 g (13,500 rpm, JA 25.50 rotor) at 4°C. The resulting supernatant was applied to the 
GSFF column (5 ml) for 40 min at RT on the shaker. The beads were subsequently washed 
3 times with 10 ml of lysis buffer and once with 10 ml of cleavage buffer. Cleavage of the 
fusion protein was performed on the beads o/n with PreScission protease (80 U/ml of beads) 
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in cleavage buffer. Finally, the cleaved Stau2CT was eluted 3 times with 5 ml of cleavage 
buffer and dialyzed o/n at 4°C. Samples for SDS-PAGE were prepared (see section 2.2.3.1). 
2.2.3.4 PURIFICATION OF GST-STAU2CT  
Lysis, preparation of the lysis supernatant and binding to the beads was performed as 
described in section 2.2.3.3. Afterwards, the beads were washed 3 times with 10 ml of lysis 
buffer. To dissociate bacterial chaperones associated with the overexpressed recombinant 
protein, the beads were incubated with 5 mM ATP/5 mM MgCl2 solution 2 times 15 min at 
RT. The beads were then packed into a column, washed once with 10 ml of Buffer A and 
connected to the BioLogic purification system. After extensive washing with Buffer A, 
GST-Stau2CT was eluted with reduced glutathione using a linear gradient of 0% - 100% 
Buffer B over 50 ml at a flow rate of 0.5 ml/min. The fraction size collected was 1 ml. The 
peak fractions were pooled and dialyzed o/n against 2 l of PBS at 4°C. If necessary, the 
resulting protein solution was concentrated to 1.3 – 1.4 mg/ml using Vivaspin concentrators 
(MWCO 10 kD). Samples for SDS-PAGE were prepared (see section 2.2.3.1). 
For antibody production, the purified GST-Stau2CT was aliquoted to 1 mg/tube and used as 
an antigen for injecting rabbits. Before injection, Preimmune sera (PIS) of six different 
rabbits were tested for background on Western blots of E17 postnuclear supernatant (PNS) 
samples. The two rabbits with the lowest signal especially at the size of Stau2 (between 52 
and 62 kD) were chosen and injected with the purified GST-Stau2CT (injections and bleeding 
performed by Harald Höger). 
2.2.4 ANALYSIS OF PROTEINS 
2.2.4.1 SDS-PAGE 
Gels (0.75 mm) for SDS-PAGE based on Laemmli were prepared as described in the material 
section (Laemmli 1970). 
After individual sample preparation, all the samples for SDS-PAGE were combined with 
6x Laemmli buffer and boiled for 8 min at 95°C. For analysis, samples were loaded onto the 
gel together with a suitable marker. Proteins were separated for 90 min at a constant 
voltage of 100 V which resulted in ~20 mA/gel. After SDS-PAGE, the gel was pre-washed in 
water and either stained with Coomassie or silver or subjected to Western blotting. 
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Coomassie 
Gels were stained with Coomassie staining solution either o/n at RT or with pre-heated 
staining solution (to 80°C) for 30 min. Destaining was performed with destaining solution 
until the background was removed. Finally, after equilibration of the gels in water, they were 
scanned using the Li-Cor scanner. 
 
Silver staining 
The gel was fixed in fixation solution for at least 30 min or o/n and subsequently incubated 
with reducing/cross-linking solution for 10 min. After 3 washing steps with water, the gel 
was incubated with silver solution for 15 min. Following a short rinse with water, proteins 
were visualized with developing solution until an optimal intensity of the bands was obtained. 
The reaction was stopped with 3% acetic acid for 10 min. Finally, after equilibrating the gel 
in water, it was scanned using the Peqlab imaging system. 
2.2.4.2 WESTERN BLOTTING 
For Western blotting, the tank blotting system from BioRad was used. The gel, filter papers 
and the membrane were soaked in cold blotting buffer and assembled into a sandwich in the 
following order starting from the cathode: sponge, 2 filter papers, gel, membrane, 2 filter 
papers and sponge.  
Proteins were blotted at constant voltage of 100 V for 90 min under constant stirring of the 
buffer and cooling on ice. Afterwards, the membrane was stained with Ponceau S to check 
for the quality of blotting. Blocking of the membrane was performed for at least 30 min at 
RT in DetectorTM Block solution. Incubation with the primary antibody, diluted in DetectorTM 
Block was carried out either for 2 h at RT or o/n at 4°C. The membrane was washed at least 
2 times for 15 min at RT with 1x TBST, then the secondary antibody was added for 
30-40 min at RT. Finally, the blot was washed as before and scanned using the Li-Cor 
scanner.  
2.2.5 GEL FILTRATION OF RAT BRAIN LYSATES 
Preparation of the sample 
An aliquot of frozen E17 rat brains (30 brains) was thawed and the tissue was homogenized 
in 5 ml HS with 10 stokes at 900 rpm at 4°C. The homogenate was centrifuged at 12,500 g 
for 8 min at 4°C, which resulted in the separation of the postnuclear supernatant (PNS). The 
PNS was then subjected to a differential centrifugation starting with 40,000 g (27,000 rpm, 
  35 
Materials and methods 
TLA 100.3 rotor) for 40 min at 4°C. The resulting supernatant S40 was further centrifuged at 
120,000 g (47,000 rpm, TLA 100.3 rotor) for 1 h at 4°C. The final supernatant S100 was 
then recovered (diluted to 2.5 ml) and filtered through 0.45 µm filter prior to loading onto 
the S-300HR column.  
 
Gel filtration on Sephacryl S-300HR 
The S-300HR 26/60 column was equilibrated with at least 3 column volumes of GF buffer. 
Two ml of the S100 supernatant were loaded and separated at a flow rate of 0.4 ml/min. 
Fractions of 3 ml were collected. For the calibration, a run of a sample containing 4 mg of 
each marker protein from the molecular weight marker kit was separated under the same 
conditions. The elution volumes of marker proteins were then used as reference for the size 
of Stau2 RNP complexes. 
 
Protein isolation from the fractions 
Proteins from 300 µl of each fraction were subjected to TCA precipitation as described 
(Bensadoun and Weinstein 1976). Briefly, 0.02% DOC was added to the protein solution 
(4 µl from the 1.5% stock), vortexed and incubated on ice for 5 min. Then 11% TCA was 
added (41.3 µl from 80% stock) and incubated on ice for 1 h. Precipitated proteins were 
recovered by centrifugation at maximum speed (20,000 g) using a top-bench Eppendorf 
centrifuge. The protein pellet was washed with 1 ml cold acetone (-20°C), centrifuged for 
5 min at 14,000 rpm at 4°C and allowed to air-dry. Then the proteins were redissolved in 
10 µl of 100 mM Tris pH 8.5 and prepared together with an aliquot of 5 µl of the input 
(S100) for SDS-PAGE. The samples were submitted to Western Blotting. The remainder of 
the fractions (2.5 ml) was saved for a subsequent IP experiment. The fractions were 
combined with 500 µl 50% glycerol in GF buffer in order to freeze them in liquid nitrogen for 
storage at –80°C. 
 
RNA isolation from the fractions 
200 µl of the fractions were used to isolate RNA with the mirVanaTM Kit (see section 2.2.9.1). 
 
Immunoprecipitation from GF fractions of the E17 brain lysates 
As an input material, fractions 29 to 37 containing Stau2 protein were pooled (20 ml), 
concentrated up to 2.5 ml using a Vivaspin concentrator (MWCO 10 kD) and used for a 
subsequent IP as described in section 2.2.7. 
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2.2.6 PREPARATION OF ANTIBODY-COUPLED BEADS FOR IP 
The protocol used was adopted from Daniela Karra in the lab (D. Karra, 2008, PhD thesis). 
2.2.6.1 AFFINITY PURIFICATION OF ANTIBODIES 
The immunized serum (from rabbit H7) containing the antibody directed against mouse 
Stau2FL was thawed and diluted 2-fold with Tris buffer. Magnetic beads (0.9 ml) coated with 
4.56 mg of GST-Stau2FL protein (prepared by Martina Schwarz) were equilibrated with Tris 
buffer. The diluted serum was incubated with the magnetic beads for 3 h at 4°C rotating. 
Afterwards, the supernatant was saved for testing as well as for a subsequent 2nd round of 
affinity purification. Beads were then washed 3 times with 40 ml Tris buffer and once with 
40 ml of 1.5 M NaCl (in water) for 10 min at 4°C. The bound IgGs were eluted with 5 ml 
glycine pH 2.5 containing 1 tablet of protease inhibitors for 5 min at RT on the shaker. The 
glycine elution was collected into a Falcon tube containing 1 ml of 1 M Tris pH 8.5. In 
parallel, the beads were washed with PBS to restore the pH and stored in PBS with 0.02% 
NaN3 at 4°C, ready for the next round of affinity purification.  
The eluate containing the purified antibodies was concentrated up to 1 ml using a Vivaspin 
concentrator MWCO 50 kD by centrifugation at 4,000 rpm (rotor Heraeus #8074), at 4°C. To 
exchange the buffer, 5 ml of PBS supplemented with protease inhibitors was added to dilute 
the antibodies and subsequently this mixture was concentrated again up to 1 ml. The 
concentration of the anti-Stau2 antibody was measured using Bradford method and A280 
protein measurement. The specificity and purity of the antibody was analyzed by probing on 
Western blot of E17 PNS samples. Purified anti-Stau2 antibody was stored in PBS containing 
0.02% NaN3 at 4°C until further use. The serum was used for several rounds of affinity 
purification. 
For purification of antibodies directed against mouse Stau2CT (from rabbit R) the same 
procedure was performed (done by Anetta Konecna). However, first the serum was depleted 
of antibodies directed against the GST-tag by application to GSFF coated with GST. 
Afterwards, magnetic beads (1 ml) coated with 4 mg of GST-Stau2CT protein were used for 
purification.  
2.2.6.2 COUPLING OF THE ANTIBODIES TO PROTEIN A SEPHAROSE 
In general, approximately 1 mg of affinity-purified anti-Stau2 antibody was coupled to 500 µl 
of Protein A Sepharose beads. As a negative control, the same amount of PIS (10 mg/ml, 
from the same rabbit which produced the antibody) was coupled to the same volume of 
Protein A Sepharose. Subsequently these beads are referred to as Stau2 and PIS beads. The 
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coupling was performed in 1.5 ml Eppendorf tubes for 1 h rotating at 4°C, where the volume 
for coupling was adjusted to a minimum of 1 ml with PBS to ensure good mixing. For the 
production of non-crosslinked beads, the beads were washed 3 times with PBS and stored in 
PBS with 0.02% NaN3 at 4°C. 
For the production of crosslinked beads, the beads were washed 2 times with PBS, once with 
PBS including 350mM NaCl and 2 times with Hepes buffer pH 8.5. Crosslinking of the IgGs 
was performed with 1 ml 20 mM DMP in Hepes buffer pH 8.5 at RT for 30 min. To stop the 
crosslinking reaction, the beads were first rinsed and then incubated in 0.2 M ethanolamine 
pH 8.0 for 1 h at RT. Afterwards, two washing steps with PBS and one with water were 
performed prior to a short elution of not successful crosslinked IgGs with 1 ml of 0.2 M 
glycine pH 2.5. Re-equilibrated beads with PBS were stored at 4°C in the presence of 0.02% 
NaN3. 
To analyze the efficiency of binding/coupling, samples of the beads, 10 µl of the 1:1 slurry, 
as well as the input and non-bound IgGs were analyzed by 10% SDS-PAGE and silver 
staining.  
2.2.7 IMMUNOPRECIPITATION OF STAU2-CONTAINING RNPS 
The protocol used was adopted from Daniela Karra in the lab (D. Karra, 2008, PhD thesis). 
 
Input material 
E17 IPs: 20-24 E17 rat brains (stored at –80°C) in 2 ml 1x BEB complete (30 - 40 mg/ml) 
Adult IPs: 1 adult rat forebrain (stored at –80°C) in 3 ml 1x BEB complete (30 - 40 mg/ml) 
S100 IPs: for the preparation, see gel filtration experiments (section 2.2.5) 
 
The input material was homogenized with 10 strokes at 900 rpm (for E17 brains) or 
1500 rpm (for adult brains) in 1x BEB complete, which was supplemented with RiboLock 
(2 µl/ml), 1 mM DTT and protease inhibitors (1 tablet/10 ml). The homogenate was 
centrifuged at 20,000 g for 10 min at 4°C. The resulting PNS was pre-cleared with 100 µl of 
Protein A Sepharose for 1 hour at 4°C rotating. At the same time, 20 - 25 µl of crosslinked 
anti-Stau2 and PIS beads were blocked with 0.5 mg BSA (25 µl 20 mg/ml BSA stock) and 
50 µg yeast tRNA (5 µl 10 mg/ml stock) in 1x BEB complete for 1 hour at 4°C rotating.  
Centrifugation steps to collect the beads were carried out for 2 min at 500 g, 4°C. Beads 
were washed once with 1x BEB complete and then incubated with 300 µl pre-cleared PNS 
including 30 µg of yeast tRNAs for 1.5 hour at 4°C rotating.  
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Afterwards, the beads were washed 4 times with 1x BEB complete w/o RiboLock and once 
with PBS containing 1 mM MgCl2 (which had RT). First, the RNase elution was carried out by 
addition of 150 µl of RNase mix, composed of 150 µl PBS + 1 mM MgCl2 + 1.7 µl RNase A + 
T (5,000 U/ml RNase T1, 12 mg/ml RNase A) and the eluted proteins were collected after 
1 h incubation at RT. The beads were then washed 2 times with 1x BEB complete w/o 
RiboLock and once with ice-cold water. Second, the elution of the remaining proteins bound 
directly to Stau2 was performed with 125 µl of glycine pH 2.5 for 15 min at RT. The eluted 
proteins were collected into a tube containing 25 µl of 1 M Tris-HCl pH 8.5 to immediately 
neutralize the low pH. 
The RNase and glycine eluates were precipitated by methanol-chloroform precipitation 
method (Wessel and Flugge 1984). The protein pellets were redissolved in 15 µl of 100 mM 
Tris buffer pH 8.5 and subjected to SDS-PAGE sample preparation. As a control 3 µl of the 
input (PNS) and the unbound supernatant after IP were diluted up to 10 µl with PBS. IP 
samples were separated on 10 or 12% SDS-PAGE followed by Western blotting (see section 
2.2.4.1). In general, IP from 20 µl beads and 300 µl PNS was sufficient for one Western blot, 
for two gels the amount of the beads and the input was doubled. 
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2.2.8 RNA METHODS 
2.2.8.1 RNA HANDLING IN GENERAL 
RNase contamination should be eliminated, therefore the following precautions were taken: 
• The working space was cleaned with ethanol 
• gloves were worn and frequently cleaned with ethanol 
• Glassware was sterilized by baking for 6 h at 240°C 
• ddH2O was treated with 0.1% DEPC (diethylpyrocarbonate)  
• Solutions were prepared from RNA grade chemicals 
• Barrier tips were used for pipetting  
• RNase-free non-stick tubes from Ambion were used for miRNA experiments 
• Total RNA was stored at –20°C or –80°C in water  
2.2.9 IMMUNOPRECIPITATION OF STAU2-CONTAINING RNPS FOR RNA 
EXPERIMENTS  
The IP for subsequent RNA isolation was performed as described in section 2.2.7 with the 
following modifications: 50 µl non-crosslinked beads were incubated with 600 µl input. The 
blocking procedure was tested with and w/o yeast tRNAs, subsequently tRNAs were omitted.  
After binding of the input, beads were washed 2 times in 1x BEB complete, 0.5% NP40 and 
2 times in 1x BEB complete, 0.1% NP40. After this washing step all further steps were 
carried out according to RNA handling rules. Beads were transferred into non-stick RNase-
free tubes and washed 2 times in 5 mM Tris, 100 mM NaCl buffer. After the last washing 
step the supernatant was removed and RNA isolation using the mirVanaTM Kit was 
performed. 
2.2.9.1 MIRVANATM MIRNA ISOLATION KIT 
The original protocol according to the manufacturer (Ambion) was used with minor 
modifications. 
After IP, total RNA was isolated from Stau2 RNPs bound to the beads as shown in the table. 
Alternatively, fractions obtained after GF were used for RNA isolation. As a positive control, 
RNA was isolated in parallel from the input sample (in general PNS).  
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Sample Lysis/Binding buffer miRNA Homogenate 
additive 
Acid Phenol:Chloroform 
PNS / input – 40 µl 200 µl 24 µl 240 µl 
Beads – 50 µl 200 µl 20 µl 200 µl 
Beads – 100 µl 250 µl  25 µl 250 µl 
Fractions GF – 200 µl 500 µl 70 µl 700 µl 
 
The organic extraction and further steps of the “Total RNA Isolation Procedure” were carried 
out as described in the protocol. The RNA was eluted in 100 µl pre-heated RNase-free water 
and subjected to RNA precipitation. 
2.2.9.2 RNA PRECIPITATION AND PURITY ANALYSIS 
Eluted RNA was precipitated by the addition of 50 µl 3 M sodium acetate, pH 5.5, 0.5 µl 
glycogen (20 mg/ml) and 1 ml 1:1 ethanol/isopropanol. The mixture was incubated o/n at -
20°C. The next day, RNA was recovered by centrifugation at 20,000 g for 15 min, 4°C. The 
pellet was washed once with 1 ml of 75% ethanol, re-centrifuged and allowed to air-dry for 
a maximum of 5 min. Then the RNA was redissolved in RNase-free water (usually 8 to 15 µl) 
and the amount and purity was estimated by measurement at 260 and 280 nm. The 
remaining RNA was stored at –20°C. 
2.2.10 RNA GEL ELECTROPHORESIS 
For RNA gel electrophoresis, only special equipment was used, which was reserved for RNA 
work. A 1.5% agarose gel containing formaldehyde was prepared as follows: 
 
agarose  1.5 g 
DEPC water 73 ml 
Dissolve by heating, cool down 
under constant stirring to 55°C 
10x MOPS 10 ml 
formaldehyde, 37% 17 ml 
Pour the gel under the hood 
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A sample of 2 µg of RNA in 6 µl DEPC water was denatured by addition of 19 µl of 
formaldehyde/formamide mixture as shown in the table: 
 
mixture µl 
formamide 12.5 
10x MOPS 2.5 
formaldehyde, 37% 4 
Total 19 
 
The resulting 25 µl of the mixture were incubated at 65°C for 10 min, chilled on ice and 
combined with 2.5 µl RNA loading dye mix. 
The gel was pre-run in 1x MOPS buffer for 10 min at 5 V/cm (which makes 90 V for 19 cm 
measured between the two electrodes). Afterwards samples and size markers were loaded 
and electrophoresis was performed at 90 V for 4 h under the hood. RNA was visualized by 
staining with ethidium bromide in a bath of 1x MOPS. 
2.2.11 3’-END RNA LABELING WITH [32P] PCP 
A 15% denaturing polyacrylamide gel containing urea (1 mm) was prepared as shown in the 
following table: 
 
urea 12 g 
10x TBE Buffer 2.5 ml 
40% acrylamide (19:1) 9.3 ml 
DEPC water up to 25 ml 
dissolve urea at RT, shaking 
APS (10%) 125 µl 
TEMED 25 µl 
 
The gel was prepared at RT and allowed to polymerize for 20-30 min. 
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For the RNA labeling reaction, the following mixture was prepared. 
 
RNA 0.5 µg 
DMSO 3 µl 
10x T4 Ligase buffer  2 µl 
0.1 mM ATP  1.2 µl 
0.1 M MgCl2  2 µl 
0.1 mg/ml BSA  2 µl 
DEPC water up to 18 µl 
 
Then 1 µl T4 RNA Ligase and 0.5 µl of [32P] pCp were added and the reaction mixture was 
incubated at 15°C for 60 min in a water bath. In the meantime, the gel was pre-run at 
30 mA constant for 20 min to obtain an optimal temperature of 45-50°C. After incubation, 
RNA samples were desalted using the MicroSpin G-25 columns according to the 
manufacturer’s instructions. The desalted flow-through was combined with 20 µl of gel 
loading buffer II, heated at 95°C for 3 min and loaded hot onto the gel. As a size control, 
10 µl of the decade marker (Ambion) was used, which was prepared according to the 
protocol supplied. The gel was run in 1x TBE at 30 mA constant for 40 min. The running 
buffer was collected as radioactive liquid waste. The gel was wrapped with Saran and 
exposed to an Imaging Screen K from 10 min to o/n at RT. 
2.2.12 END POINT RT-PCR FOR SELECTED MIRNAS 
RT-PCR was performed using the mirVanaTM qRT-PCR miRNA Detection Kit from Ambion.  
 
Set-up of the reverse transcription (RT): Set-up of the PCR reaction: 
 
RT 10 µl  PCR 25 µl 
5x RT-buffer 2 µl   RT-mix 10 µl 
Enzyme mix 0.4 µl  5x PCR-buffer 5 µl  
RNA (25 ng/µl) 1 µl  Taq (1 U) 0.2 µl 
1x RT-primer 1 µl  PCR-primer set 0.5 µl 
RNase free water 5.6 µl  RNase free water 9.3 µl 
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RNA was reverse transcribed for 30 min at 37°C using a thermal cycler, afterwards the 
enzyme was inactivated at 95°C for 10 min. The complete 10 µl of RT-mix were used for 
setup of the PCR reaction, the composition is shown in the table. The PCR mixture was 
placed into a pre-heated thermal cycler and the following program was run. 
 
Initial denature:   95°C for 3 min 
Cycling (27 cycles):  95°C for 45 sec 
60°C for 60 sec 
 
The PCR products (90 bp) were combined with 6x Orange LD and analyzed on 3.5% agarose 
gels (Top Vision LE GQ Agarose). As a size marker, 7 µl of the O’GeneRulerTM Low Range 
(700 – 25 bp) were used. DNA was visualized by incubation of the gel in a 1:10,000 dilution 
of SYBR® GOLD in TAE for 10-20 min and subsequent monitoring of the bands using a 
SYBR® photographic filter. 
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3 RESULTS 
3.1 PURIFICATION OF GST-STAU2CT FOR ANTIBODY 
PRODUCTION 
3.1.1 CLONING OF STAU2CT INTO PGEX-6P-2 
For many experiments, the quality or specificity of the antibodies used is crucial, e.g. for 
immunoprecipitation (IP). To generate specific antibodies against Stau2, a new antigen 
consisting of GST fused to the C-terminal (CT) part of mouse Stau2 (GST-Stau2CT) was 
produced. The C-terminal part of the Stau2 protein covers the region starting from threonin 
379 until the C-terminal isoleucin 512, including the tubulin-binding domain (TBD) and the 
RNA binding domain (RBD) 5. The construct was initially described in Duchaine et al. 2002 
where it was cloned from mouse brain into pBluescript SK(+) at the EcoRV site and later 
subcloned into pGEX-4T-2 at the NotI/SalI sites.  
The aim was to insert Stau2CT into the bacterial expression vector of the pGEX-6P series, 
which contain a cleavage site for the PreScission protease in order to cleave the GST-tag 
after purification. For maintaining the correct reading frame, pGEX-6P-2 was needed and 
therefore constructed from pGEX-6P-1 and pGEX-4T-2 (see section 2.2.2.1). In Figure 3.1A, 
the plasmid map of the empty pGEX-6P-2 vector is shown. It includes an ampicillin 
resistance gene for positive selection, the coding sequence for GST right before the 
PreScission cleavage site and a multiple cloning site (MCS). Stau2CT was inserted directly 
after the GST sequence using NotI and SalI sites (Figure 3.1B). The vector and the insert 
used for ligation are shown in Figure 3.1C. Clones were tested by restriction digestion, 
yielding 8 clones carrying the correct construct. Clone #2 was used for subsequent 
expression of GST-Stau2CT in BL21 cells. 
3.1.2 EXPRESSION AND PURIFICATION OF THE PRESCISSION PROTEASE 
The main advantage of the pGEX-6P series is the PreScission cleavage site for removing the 
GST-tag from expressed fusion proteins. Thus, the PreScission protease was expressed and 
purified. The construct (GST-3C) was obtained from Andi Geerlof (see section 2.1.4) and 
contains the GST-tagged protease. Therefore, on the one hand the protease can be purified 
using a Glutathione SepharoseTM 4 Fast Flow (GSFF) column which binds to GST. 
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On the other hand, this GST-tag allows to trap the protease on the beads during cleavage of 
the GST-tag from a fusion protein. The protease was expressed in BL21 cells as described in 
section 2.2.3.1. BL21 cells are deficient in both lon and ompT proteases, therefore they are 
commonly used for expression of recombinant proteins. As seen in Figure 3.2A, the protease 
was produced upon induction with IPTG and the major portion of the protein was found in 
the supernatant, indicating that it was soluble. The lysate supernatant was then subjected to 
purification on a GSFF column. As shown in Figure 3.2B, the column was saturated with 
GST-PreScission protease since there was still a significant amount of the protein found in 
the flow-through (FT) as well as in the washing step. This left the possibility to re-purify the 
protease from the FT or increase the volume of the column.  
The eluate showed a single protein band, proving the purity and the correct size of the 
protease. This is also visible from the elution profile containing one symmetric peak (Figure 
3.2C). The peak fractions 11 to 17, which included the main part of the protein, were 
pooled. The obtained concentration was 7.36 mg/ml. The specific activity of the PreScission 
protease usually obtained using this protocol is 1,000 U/mg. Therefore, based on the 
concentration and the assumed specific activity this purification yielded a protease activity of 
approximately 7,360 U/ml. 
3.1.3 EXPRESSION AND PURIFICATION OF STAU2 PROTEINS 
3.1.3.1 EXPRESSION AND PURIFICATION OF STAU2CT 
The purpose of the following experiments was to obtain a pure antigen suitable for antibody 
generation. The advantage for production of Stau2CT via cleavage of the GST tag was the 
possibility to inject “tag-free” antigen. This prevents production of antibodies directed 
against the tag and therefore abolishes the need for removing them.  
GST-Stau2CT was expressed in BL21 cells via induction with IPTG. Comparing the amount of 
GST-Stau2CT in the total lysate and the lysate supernatant showed that half of the protein 
was lost in insoluble form (inclusion bodies) in the pellet after centrifugation (see Figure 
3.3A). The purification was performed by binding of GST-Stau2CT to the GSFF column and 
subsequent cleavage of the Stau2CT using the PreScission protease. A representative 
purification is shown in Figure 3.3A. The binding capacity of the column was exceeded by 
the amount of protein applied, as some protein was still found in the FT. Upon binding, GST-
Stau2CT, its degradation products and also some other proteins, namely DnaK, were bound. 
DnaK is a heat shock protein involved in correct folding of nascent proteins in E. coli and 
may co-purify with GST fusion proteins. 
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After cleavage, only the GST tag and the PreScission protease (which also carries a GST-tag) 
remained, indicating that the cleavage of GST-Stau2CT was complete. However, the amount 
of cleaved Stau2CT was much less than expected from the amount of bound GST-Stau2CT. 
This observation was independent from the method used for quantification: Coomassie 
staining, Bradford, UV-measurement. After dialysis, the concentration levels were even 
lower. To exclude any unspecific proteolytic activity, purified GST-Stau2CT and BSA were 
incubated over a time of 3 h with or without PreScission protease. This resulted in no 
decrease of the protein amounts of BSA and GST-Stau2CT, therefore no unspecific 
degradation occurred by incubation with PreScission protease (data not shown).  
Because the Bradford assay essentially measures the amount of arginine and hydrophobic 
amino acid residues, the amino acid composition can bias the results depending on the 
percentage of arginine or hydrophobic amino acids in each protein. Therefore, the ProtParam 
tool from the ExPasy webpage was used to calculate several protein parameters, shown in 
the following table. One of the parameters was the molar extinction coefficient computed 
from the amino acid composition of either the GST-Stau2CT fusion protein or cleaved Stau2CT 
protein. Usage of this molar extinction coefficient to calculate the concentration from the 
absorption at 280 nm (A280) gave more reliable results compared to Bradford or conventional 
UV-measurement (with an averaged coefficient). 
 
protein  Amino 
acids 
Molecular 
weight (kD) 
Isoelectric 
point 
Molar extinction 
coefficient (/M cm) 
Stability index 
GST-Stau2CT 436 48.6 6.53 53205 39.68 = stable 
Stau2CT 210 22.1 8.84 10095 43.74 = unstable 
 
If the two methods (UV-measurement using the molar extinction coefficient and Bradford 
measurement) were compared, the following results were obtained. For GST-Stau2CT, the 
concentration was reduced by a factor of 0.87; meaning that the Bradford method slightly 
overestimated the concentration. For cleaved Stau2CT, an increase of the quantity by a factor 
of 2.45 for was found, leading to the assumption that Bradford method underestimated the 
concentration of cleaved Stau2CT. The correction of the concentrations decreased the 
discrepancy between quantities of GST-Stau2CT and cleaved Stau2CT, but still the yield of 
Stau2CT after cleavage and concentrating was below 20-30%. One possible reason might be 
the high instability of Stau2CT (as seen by the stability index), making Stau2CT an unsuitable 
antigen for injection and antibody production. Thus, the approach of purifying Stau2CT via 
cleavage of the GST tag was abandoned.  
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Instead, it was decided to produce GST-Stau2CT, which was previously shown by Anke 
Deitinghoff in the Kiebler lab to yield specific antibodies. 
3.1.3.2 EXPRESSION AND PURIFICATION OF GST-STAU2CT 
The following section describes the purification of GST-Stau2CT to obtain a stable, highly pure 
antigen suitable for antibody production. Due to the importance of the quality of the antigen 
for antibody specificity, the purification protocol was modified to the final version described 
in the material and method section 2.2.3.4. An ATP/MgCl2 incubation step was included after 
binding of the fusion protein to GSFF. This step should dissociate the interaction of the 
recombinant protein with the chaperone DnaK. Afterwards the column was connected to the 
BioLogicLP system (BioRad) and GST-Stau2CT was eluted using a glutathione gradient. The 
advantage of elution using the LP system was the small volume of elution, leading to higher 
concentrations.  
The purification process is shown in Figure 3.3B. Since there is still unbound GST-Stau2CT in 
the FT, re-binding of the FT or increasing the volume of the Sepharose would be possible. In 
Figure 3.3C, the elution profile is shown. From this experiment, fractions 14 – 19 were 
pooled. This approach yielded a sufficient amount of stable protein which was relatively free 
of impurities, especially the contaminating chaperone DnaK. Just a very faint band is visible 
at 70 kD in the concentrated eluate, leading to the conclusion that the ATP/MgCl2 incubation 
is sufficient to dissociate the interaction of the recombinant protein with DnaK. The lower 
bands in the eluate refer to degradation products, which were considered to be no problem 
for antigen purity (tested by WB, data not shown). 
This purified GST-Stau2CT was used as an antigen for antibody production. After testing the 
specificity, the generated antibody could be used for WB or IP experiments.  
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3.2 PROTEIN COMPOSITION OF STAU2 COMPLEXES 
3.2.1 AFFINITY PURIFICATION OF ANTI-STAU2 ANTIBODIES AND 
PREPARATION OF ANTIBODY-COUPLED BEADS 
Immunoprecipitation is a suitable method to investigate the composition of Stau2-containing 
particles in rat brain. Using this approach, it is possible to specifically precipitate Stau2 with 
all associated proteins, RNAs and other factors. For the specificity of the IP, the high quality 
of the antibody used is essential. Therefore, all the IP experiments were performed using 
affinity-purified anti-Stau2 antibodies. Two different anti-Stau2 antibodies were used: H7 
derived from rabbit H7 immunized with His-tagged mouse Stau2 full-length (FL) protein 
(His-Stau2FL) and R derived from rabbit R immunized with the C-terminal part of mouse 
Stau2 fused to a GST-tag (GST-Stau2CT). As a control, the pre-immune sera (PIS) from the 
two corresponding rabbits were used in parallel IPs. 
 
In Figure 3.4A, the affinity purification of anti-Stau2 antibodies from rabbit H7 is shown. For 
this purpose, the serum was applied to magnetic beads coated with the GST-Stau2FL protein. 
As the His-tagged protein was used for immunization, a GST-tagged Stau2 protein was used 
for the affinity purification. It is important not to purify the antibodies on the antigen 
including the same tag used for immunization, as this will result in purification of additional 
antibodies directed against the tag itself. After binding and thorough washing, the IgGs were 
eluted and tested for specificity. As seen in Figure 3.4A, the serum detected primarily three 
isoforms of Stau2 along with a number of additional bands. After purification, the most 
prominent bands were the ones for the two most abundant isoforms of Stau2 (59 and 
52 kD), whereas there was just a faint band for the 62 kD isoform. This reflects the levels of 
expression of the Stau2 isoforms in the brain. Importantly, with the affinity-purified antibody, 
most of the non-specific bands disappeared. As obvious from the flow-through, several 
rounds of purification were performed from one serum aliquot due to a high titer of anti-
Stau2 antibodies.  
The affinity-purified anti-Stau2 antibody as well as equivalent amounts of the PIS were then 
coupled to Protein A Sepharose beads, as shown in Figure 3.4B (subsequently referred to 
Stau2 and PIS beads). The binding was complete, as there is no antibody left in the 
supernatant after binding. The crosslinking of the antibodies with dimethylpimelimidate 
(DMP) led to covalent binding to the Sepharose. Therefore, the samples of the beads after 
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crosslinking showed only weak bands for heavy and light immunoglobulin (Ig) G chains, 
which represent a minor leakage. The amount of Stau2 and PIS IgGs coupled to beads was 
equivalent, which is an important point for subsequent IP. The identity of the band slightly 
below 70 kD in the PIS beads is not known. It was also present in the affinity-purified anti-
Stau2 antibody but it did not bind to the Protein A Sepharose. Both IgG-coupled beads were 
then ready to be used for IP experiments. 
 
3.2.2 PROTEIN CANDIDATES IN STAU2 COMPLEXES 
Currently, a comprehensive proteomic analysis of Stau2 RNPs is under intensive investigation 
in the lab (D. Karra and M. Kiebler, in preparation). Since the main goal of this thesis was to 
address whether small non-coding RNAs, such as miRNAs, are present in these complexes, 
focus was put on few selected candidate proteins known to be involved in miRNA processing 
and function. 
For this purpose, IP experiments were performed using anti-Stau2 antibodies. The 
expression of Stau2 peaks during the two first weeks after birth and then progressively 
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decreases until adulthood (unpublished data). Therefore, it was decided to analyze and to 
compare Stau2 complexes isolated from developing (E17) and adult rat brain.  
As described in section 2.2.7, Stau2 complexes were immunoprecipitated from a postnuclear 
supernatant (PNS) of either embryonic (Figure 3.5A) or adult (Figure 3.5B) rat brain using 
antibody-coupled Sepharose (in this case from rabbit H7). The proteins from these Stau2 
complexes were subsequently subjected to a two-step elution. First, by adding an 
RNase A/T1 mixture to the beads with immunoprecipitated Stau2 complexes, the RNA was 
digested, which resulted in release of all proteins bound indirectly to Stau2 via RNA. This is 
referred to as RNase elution. In a second step, a shift to a low pH led to the dissociation of 
antigen-antibody interactions and thereby eluting Stau2 together with all directly associated 
proteins. This is referred to as low pH elution. This two-step procedure allowed to distinguish 
between Stau2 indirect interactors via RNA and Stau2 direct protein-protein interactors. In 
parallel to Stau2 beads, the IP was performed with PIS beads as a negative control.  
 
After IP, the eluates were analyzed by Western blot using indicated antibodies. To confirm 
the functionality of the IP, it was probed for Stau2, which was present in low pH elution of 
both, E17 and adult IP. Upregulated protein factor (Upf) 1, an RNA helicase involved in 
nonsense-mediated decay (NMD), reviewed in Chang et al. 2007, turned out to be a good 
positive control for the IP. It was present in the RNase elution as well as to a minor extent in 
the low pH elution from IPs of E17 and adult rat brain.  
Ago proteins, protein activator of the interferon-induced protein kinase PKR (PACT) and 
FMRP are proteins known to be involved in the RISC (Peters and Meister 2007; Lee et al. 
2006; Jin et al. 2004). Their presence would give a first hint for the link of Stau2 and the 
miRNA pathway. For the IPs from E17 rat brain, all three proteins were found in the RNase 
elution but not in the low pH elution. This indicates that they are RNA-dependent interactors 
of Stau2. In more detail, two Ago isoforms and all three FMRP isoforms showed a weak 
signal in the Stau2 IP but none in the control. However, it was not possible to distinguish 
which two of the four Ago isoforms co-precipitated because of cross-reactivity of the 
antibody (therefore, the result is simply referred to as co-IP with Ago). The weak 
co-precipitation leads to the conclusion that the interaction is specific, but the abundance of 
these proteins in Stau2 complexes is rather low. The intensity of the PACT signal in Stau2 IP 
was comparable to the signal in the input and only a very faint band could be seen in the PIS 
IP. Therefore, the abundance of PACT in Stau2 complexes is higher than for Ago and FMRP. 
eIF6 was co-precipitated with Stau2 (and to a lower extent also with the PIS) and found 
both in the RNase and the low pH elution. This suggests a partial direct interaction with 
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Stau2. Recently, eIF6 has been shown to have a repressive function on mRNA translation by 
regulating the recruitment and joining of the large ribosomal subunit (Chendrimada et al. 
2007). eIF4E and eEF1α are factors involved in the initiation and elongation of translation. 
Their complete absence in Stau2 IPs is pointing to the fact that mRNAs in Stau2 complexes 
are not actively translated. L7a and S6, two ribosomal proteins gave information about the 
association of ribosomes with Stau2 complexes. L7a is found in both RNase and low pH 
elution, however, S6 is present just in the low pH elution. This leads to the conclusion that 
Stau2 directly interacts with ribosomes, in particular with ribosomal proteins, as previously 
suggested (Duchaine et al. 2002).  
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The results for the IPs from adult rat brain were different to those from E17 rat brain. In this 
case, a co-precipitation was possible only with Upf1, two Ago isoforms and to a low extent 
also with eIF6. All these interactions were RNA-dependent. PACT and FMRP were completely 
absent in the adult Stau2 IP and it was also not possible to co-precipitate L7a or S6. 
However, the absence of eIF4E and eEF1α in IPs from adult rat brain proves that also in this 
condition, mRNAs in Stau2 complexes are not actively translated.  
These differences could result from a lower IP efficiency in the adult brain. Therefore, low 
abundant Stau2 interactors are less likely to be found. Still, the possibility remains, that 
Stau2 complexes have different compositions depending on the developmental stage. The 
absence of the two ribosomal proteins leads to the question, whether adult Stau2 is less 
associated with ribosomes.  
Summarizing, the IP from the adult rat brain has to be further optimized until any final 
conclusions concerning the differences of E17 and adult Stau2 complexes can be drawn. 
3.3 RNA COMPOSITION OF STAU2 COMPLEXES 
3.3.1 RNA ISOLATION FROM STAU2 RNPS 
The main interest of this work was to investigate the RNA composition of Stau2 complexes, 
especially to search for the presence of small RNAs. For this purpose, the complexes 
containing Stau2 were immunoprecipitated as described in the previous section using anti-
Stau2 antibodies. But instead of the two-step elution performed for detection of proteins, the 
beads were subjected to RNA isolation right after binding. In order to test the efficiency of 
the RNA isolation and the quality of the RNA obtained, a standard RNA electrophoresis of 
2 µg of RNA was performed. The quality of the RNA can be assessed by the presence of 
intact ribosomal RNAs, 28S rRNA (4,718 nt) and 18S rRNA (1,874 nt). Typically, the amount 
of 28S rRNA is twice the amount of 18S rRNA. However, the presence of rRNAs in Stau2 IP 
could also confirm the interaction of Stau2 with ribosomes on the RNA level. The results are 
shown in Figure 3.6. Three different total RNA samples were loaded: E17 PNS, adult PNS 
and the supernatant after 120,000 g centrifugation (S100) from E17 brains. The quality of 
the RNA samples was good except that the ratio between 28S/18S rRNA in the RNA from the 
S100 fraction was approximately 1:1. Indeed, at the bottom of the gel a cloud was visible, 
which could refer to degraded RNA. The reason for this can be the long storage of the RNA 
at –20°C before running this gel.  
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It is interesting to note that the amount of rRNA varies among samples. It is higher for E17 
PNS compared to adult PNS, but also higher in E17 PNS compared to the S100 fraction from 
E17 brains. Due to the fact that the same amount of RNA was loaded, one could conclude 
that the ribosome content is different between E17 and adult rat brain. The variation in the 
rRNA amount between PNS and the S100 fraction from E17 brain results very likely from the 
fact that the S100 fraction is highly enriched for free cytosolic ribosomes compared to PNS, 
which contains membrane-associated ribosomes and polysomes too. When the IP samples 
are compared to the PNS samples, it is obvious that after the Stau2 IP the rRNA amount is 
equivalent to the PNS. This confirms the results from the protein IPs, namely the presence of 
L7a and S6, and therefore strongly suggests the association of Stau2 particles with 
ribosomes. In the control IPs with either PIS or Protein A Sepharose, only very weak or no 
bands for 28S and 18S rRNA were observed. This leads to the conclusion that the interaction 
of Stau2 with the ribosomes is specific. 
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3.3.2 RNA LABELING EXPERIMENTS – A SEARCH FOR MIRNAS 
In order to clarify whether Stau2 particles contain miRNAs, a highly sensitive experimental 
setup to visualize small RNAs needed to be established. IP experiments with anti-Stau2 
antibody were performed as described, with some modifications for subsequent optimal RNA 
labeling. Total RNA was isolated after IP using the mirVanaTM Kit not to lose small RNAs 
during the isolation procedure. Because it is not possible to visualize precise bands of small 
RNAs (between the size of 20 and 40 nt) on a standard agarose gel stained with ethidium 
bromide, it was decided to use radioactive labeling for RNA visualization. T4 RNA Ligase was 
used for the ATP dependent 3’ labeling of RNA with cytidine 3',5'-bis [α-32P] phosphate 
(pCp). The optimal composition of the labeling buffer, especially the concentration of DMSO, 
BSA and MgCl2, which enhance labeling of small RNAs, was tested (data not shown). RNA 
was separated on a denaturing 15% polyacrylamid gel containing urea.  
 
In Figure 3.7, the results for the labeling of RNA from IPs from E17 rat brain are shown. For 
comparison, two experiments are presented, in which two different Stau2 antibodies were 
used, directed against His-Stau2FL (H7) and GST-Stau2CT (R) (Figure 3.7A and B, 
respectively). For both antibodies, two blocking conditions, with or without yeast tRNAs to 
prevent unspecific RNA binding during IP, were tested. For each experiment, two different 
exposure times are depicted, in order to visualize also very weak signals.  
The following results described in Figure 3.7 were obtained for both anti-Stau2 antibodies 
used. The E17 PNS represents the input used for IP. Signals from the tRNAs (80-90 nt) and 
presumably the 5S (120 nt) and 5.8S rRNAs (160 nt) were the most prominent labeled RNAs. 
In the Stau2 IP, 5S and 5.8S rRNAs were co-precipitated and exhibited the strongest signals. 
In control IPs with PIS or Protein A Sepharose, these RNA species were found too, but to a 
minor extent. It is noteworthy, that the PIS of H7 anti-Stau2 antibody gave a relatively 
strong background RNA signal compared to the PIS of R anti-Stau2 antibody. Thus, these 
results are consistent with the presence of 28S and 18S rRNAs as well as ribosomal proteins 
in the Stau2 IP and further support the conclusion that Stau2 complexes are associated with 
ribosomes.  
 
In addition to small rRNAs, tRNAs were also co-precipitated with Stau2 beads (green 
asterisks). Importantly, a much higher tRNA signal was obtained in IPs where yeast tRNAs 
were included during blocking. There seemed to be specific RNAs of 80, 50 and 35 nt in size 
that co-precipitated with Stau2 but only to some extent with PIS and Protein A Sepharose 
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(green arrows). With a closer look at a sample of labeled yeast tRNAs alone, the pattern of 
the radioactive signal turned out to be similar to the one in the Stau2 IP including yeast 
tRNAs. The two lower bands of 50 and 30 nt in size, respectively, originate very likely from 
yeast tRNA degradation upon several rounds of freeze/thaw of the stock solution.  
 
In Stau2 IP experiments without tRNAs for blocking, still RNAs at ~70 nt in size (possibly 
tRNAs) were co-precipitated but to a much lower extent (red asterisks). This led to the 
assumption that Stau2 complexes can specifically interact with structured tRNAs, however, 
the strength of this interaction does not resemble the situation in vivo. Moreover, the signal 
coming from degraded tRNAs could mask a signal of potential miRNAs. As a consequence of 
these findings, tRNAs were not used for Stau2 RNA IPs in later experiments. Alternatively, 
the signal at 70 nt in size could also originate from pre-miRNAs but no definite evidence can 
be drawn from RNA PAGE experiments. 
Most interestingly, small RNAs between 50 and 20 nt in size (red arrows) were associated 
with Stau2 complexes. These signals were completely missing in the negative controls, 
therefore they can be considered as specific. For both antibodies, two bands were detected 
at about 22 and 40 nt in size, but weaker signals were also present at 50, 35 and for the IP 
with H7 antibody also at 24 nt in size. This led to the first assumption that miRNAs and 
another classes of small RNAs are present in Stau2 complexes in E17 rat brain.  
 
In IPs from adult rat brain, the results were slightly different as shown in Figure 3.8. The 
experimental setup using two different anti-Stau2 antibodies directed against His-Stau2FL 
(H7) and GST-Stau2CT (R) (Figure 3.8A and B, respectively) was the same as for E17 brain. 
Also the two blocking conditions tested, with and without yeast tRNAs, as well as two 
different exposure times are shown. 
Again, the results described hold true for both anti-Stau2 antibodies used. The use of tRNAs 
for blocking led to the same misleading signals (green arrows and asterisks) as in the E17 IP. 
Therefore, also for the adult rat brain, tRNAs were excluded from Stau2 RNA IPs. 
The adult PNS shows signals from the tRNAs (80-90 nt) and presumably the 5S (120 nt) and 
5.8S rRNA (160 nt). As for E17 brain, the most prominent RNAs co-precipitated in the Stau2 
IP were 5S and 5.8S rRNAs as well as tRNAs (red asterisks). These results led to the 
conclusion that also in adult rat brain Stau2 is associated with ribosomes (in contrary to the 
findings on the protein level). 
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Unfortunately, it was not possible to visualize small RNAs between 50 and 20 nt in size 
associated with Stau2 complexes. The reason for this was a high background in the Stau2 
IP, which made it impossible to see distinct bands. miRNAs and other small RNAs may be 
present in Stau2 complexes from adult rat brain, but a reduction of the background is 
necessary to visualize those small RNAs. Also, the amount of RNA precipitated was lower 
than for the E17 brain, therefore there is still a need for optimization of the adult IP. 
 
The results of the radioactive labeling experiments are the first indication that miRNAs but 
also other small RNAs might be associated with Stau2 complexes in E17 rat brain. In adult 
rat brain, the results are not yet clear. Altogether, the confirmation of these results with two 
different anti-Stau2 antibodies provides convincing evidence.  
3.3.3 GEL FILTRATION EXPERIMENTS TO SEPARATE DIFFERENT STAU2 
COMPLEXES 
Recently, miRNAs and siRNAs were found in separate complexes in C. elegans, named 
miRNPs and siRNPs, respectively (Gu et al. 2007). They were isolated based on their 
different sizes by gel filtration: miRNPs appeared to fractionate at 200 kD whereas siRNPs 
seemed to constitute smaller, 60 kD complexes. Previous research in the Kiebler lab 
pioneered a similar fractionation for Stau1 and Stau2 RNPs (Mallardo et al. 2003): According 
to gel filtration experiments performed during this work, at least two distinct groups of 
Stau2-containing particles exist in adult rat brain, high molecular weight granules (above 
2 MD) and smaller 700-400 kD particles. Moreover, lately even smaller complexes of Stau2, 
200 kD in size, which co-fractionated with Ago and PACT proteins were observed after GF of 
adult rat brain extracts (A. Konecna and M. Kiebler, unpublished). 
 
Based on these findings, the gel filtration experiments were repeated with the focus on RNA 
distribution, especially on detection of small RNAs in different fractions with respect to Stau2 
RNPs. As input for gel filtration served the S100 supernatant from E17 rat brain which is 
enriched in smaller RNA-protein complexes. After gel filtration, total RNA was isolated from 
the fractions and subjected to the 3’ labeling using pCp (Figure 3.9A). A clear enrichment of 
larger RNAs (>100 nt) in the fractions containing the larger complexes (fractions 4-14) and 
in parallel an enrichment of smaller RNAs (20-50 nt) in fractions containing smaller 
complexes (fractions 28-40) was observed. miRNAs were detected in fractions 30-37, which 
in parallel also contained Stau2 (Figure 3.9B). Interesting was the increase in signal intensity 
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of miRNAs and other small RNAs at 35 and 40 nt in the input (S100 fraction) compared to 
the PNS. If small RNAs are more abundant in this fraction, it could represent a better input 
for RNA IPs in order to detect miRNAs. The Western blot in Figure 3.9B showed 
co-fractionation of lower size Stau2 complexes with RISC marker proteins such as Ago, PACT 
and eIF6. These results, together with the presence of miRNAs in the same fractions, led to 
the hypothesis that a subset of Stau2 complexes might be associated with miRNAs and 
components of the RISC. However, the size of the smaller subset of Stau2 complexes was 
estimated to be 60 kD, what would contradict the presence of complexes, but rather suggest 
that they are monomers.  
 
In comparison, for the adult rat brain the size of the low molecular weight complexes of 
Stau2 co-fractionating with Ago and PACT was estimated to be 200 kD (data not shown). 
This finding points to differences between Stau2 complexes in embryonic and adult brain. To 
further test the hypothesis of low molecular weight miRNPs, an IP was performed from the 
fractions obtained from E17 GF containing small Stau2 complexes (fractions 29-37), which 
were frozen and stored at -80°C after GF. No RNA could be detected (data not shown). 
Western blotting showed that Stau2 was present in the input, but no clear IP of Stau2 was 
seen (data not shown).  
This can be explained either by that the IP did not work or it is in general not possible to 
perform IP from frozen gel filtration fractions due a stability problem of RNA-protein 
complexes. Optimization of the procedure is required in order to draw clear conclusions from 
this experiment.  
For the distribution of small RNAs in adult rat brain, no statements can be made so far, 
because no signal was found for RNAs at the size of 20-25 nt (data not shown). As the level 
of miRNA expression is generally lower in adulthood, the experiment should be repeated with 
increased amounts of starting material. Furthermore, the high background has to be 
reduced, as discussed in section 3.3.2. 
3.3.4 THE S100 FRACTION AS AN INPUT FOR LABELING EXPERIMENTS 
As observed during gel filtration experiments, the S100 supernatant appears to be enriched 
for small RNAs (Figure 3.9A). Therefore, it may represent a better input for IP experiments 
to detect small RNAs. The setup of the IPs (without tRNA blocking) and the RNA labeling was 
performed as described in section 3.3.2. 
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Figure 3.10 shows the RNA labeling after IP from the S100 fraction of E17 rat brain in two 
different exposure times. In parallel to the progressive enrichment for smaller RNA-protein 
complexes with increasing centrifugation velocity (from PNS to S40 and S100), an increase in 
small RNAs (blue arrows) was seen. The bands at 60, 45 and 35 nt as well as at 22 nt in size 
(referring to miRNAs) increased substantially in intensity in the S100 supernatant. Also in this 
case, two different anti-Stau2 antibodies were used for IP, purified from rabbit H7 and 
rabbit R, respectively. Similar to results for IPs from E17 PNS, both rRNAs and tRNAs were 
co-precipitated with the anti-Stau2 antibodies and to a minor extent also with the PIS and 
the Protein A beads. 
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When looking at the small RNAs between 60 and 20 nt in size (red arrows), they were again 
found to be associated specifically with Stau2 complexes, as the signal in the negative 
controls was completely missing. For rabbit H7, there were many different bands detected 
between 60 and 30 nt, compared to rabbit R where only two prominent bands at 60 and 
45 nt were seen. In both IPs using the two antibodies, a double band between 20 and 25 nt, 
which is very characteristic for miRNAs, was clearly detected. 
 
Unfortunately, it was not possible to detect small RNAs after IP from the S100 fraction from 
adult brain (data not shown). Again, the background was too high to see distinct bands. But 
also the enrichment of small RNAs, especially miRNAs, was not as prominent in the adult 
S100 fraction as for E17.  
Taken together, these results provide evidence that miRNAs and also other small RNAs are 
associated with Stau2 complexes in E17 rat brain, while for adult rat brain a clear conclusion 
cannot be drawn yet. All results were confirmed using two different anti-Stau2 antibodies 
yielding similar results. Validation of these interactions by a different method was the next 
important step. 
3.3.5 RT-PCR  
The previous labeling experiments of RNA isolated from Stau2 complexes provided the first 
indication for the presence of miRNAs. To verify this finding, the mirVanaTM RT-PCR system 
from Ambion was used to validate the interaction of miRNAs with Stau2 complexes. This 
method allows to investigate the presence of candidate miRNAs, since it is particularly 
interesting to identify which miRNAs are associated with Stau2.  
Five different primer sets to amplify miR-18, 26a, 128a, 134 and let7c were tested. These 
miRNAs were chosen based on different criteria: First, based on the PicTar software 
(provided by the Rajewsky lab) to predict possible miRNA – mRNA interactions. Second, 
based on a particular neuronal expression and known interactions with target mRNAs in 
neurons. miR-18 is the only predicted miRNA targeting β-actin mRNA, which could be an 
interesting issue in growth cones of embryonic neurons. On top of this, upon down-
regulation of Stau2 by siRNAs, β-actin mRNA showed reduced expression levels (Goetze et 
al. 2006). miR-26a was predicted to target CaMKIIα and MAP2 mRNA, which were known to 
be dendritically localized mRNAs in neurons (Kye et al. 2007). For investigating miRNAs in 
the adult brain, miR-128a was picked due to its onset of high expression in adult neurons 
(Kim et al. 2004). Let-7c was shown to be dendritically localized as well (Kye et al. 2007).  
  67 
Results 
 
68 
Results 
  69 
Finally, the only validated interaction of a miRNA with a target mRNA at the synapse is the 
one between miR-134 and Limk1 mRNA, therefore, miR-134 was also chosen (Schratt et al. 
2006).  
 
The mirVanaTM RT-PCR primer sets include a primer for reverse transcription and a PCR 
primer pair. Using this system, only mature but not pre-miRNAs are amplified. Already during 
reverse transcription just the indicated miRNA is transcribed with a primer consisting of a 
short miRNA-specific sequence and a loop structure. This yields a cDNA longer than the 
initial miRNA. During PCR, the cDNA is amplified with one miRNA specific primer and a 
second one complementary to the loop sequence, resulting in a PCR product of ~90 bp. 
In Figure 3.11A, the results of RT-PCR, using the primer sets described, for IP samples from 
E17 rat brain are shown. Again two different antibodies were used for the Stau2 IP (rabbit 
H7 and R) from E17 rat brain. In general, all five tested miRNAs were expressed in the 
embryonic brain, as shown by the PCR product in the PNS sample. Surprisingly, all five 
miRNAs were amplified from the RNA of Stau2 IP samples, but not from the PIS control. 
 
This finding was confirmed with both anti-Stau2 antibodies. This led to the conclusion that 
miR-18, 26a, 128a, 134 and let-7c associate with Stau2 complexes in the embryonic rat 
brain.  
Performing RT-PCR from Stau2 IP samples from the adult rat brain showed that miR-26a, 
miR-128a, and let-7c were expressed (Figure 3.11B). For miR-134, however, further 
optimization would be necessary to reduce the formation of primer dimers. miR-18 was 
expressed at a very low level in adult rat brain and it could be amplified only after 35 cycles 
(data not shown). For the three tested miRNAs, miR-26a, miR-128a, and let-7c, the same 
results as for E17 were found. All three miRNAs were present in the RNA samples after Stau2 
IP. For Stau2 IP using the anti-Stau2 R antibody, no or a very weak PCR product was found 
in the corresponding PIS control. Unfortunately, this was not the case for rabbit H7, where a 
weak signal was present in the PIS samples. The reason for this could be the high 
background in IP samples from adult brain, which was already found in the labeling 
experiments (see section 3.3.2). Due to the fact, that in general the PIS from rabbit R gave a 
lower background compared to rabbit H7, this rather reflects a problem with the specificity 
of the PIS from H7 than the problem of unspecific binding of anti-Stau2 antibody. Therefore, 
it was concluded that miR-26a, 128a, and let7c specifically associate with Stau2 complexes 
also in the adult rat brain.  
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4 DISCUSSION 
4.1 PROTEIN CANDIDATES IN STAU2 COMPLEXES 
Within this project, the composition of Stau2-containing complexes from rat brains was 
investigated using the immunoprecipitation (IP) method. A search for candidate proteins 
from E17 and adult rat brain yielded interesting results. The proteins tested for 
co-precipitation with Stau2 can be grouped as follows: mRNA decay factors, RISC-associated 
proteins, translational silencing and promoting factors as well as ribosomal proteins. 
One important remark has to be made concerning the input material for IP experiments. 
Since whole rat brains were used, the input represents a mixture of different types of 
neurons and glia cells. Thus, the conclusions drawn hold true for rat brain but not 
necessarily for neurons only or even localized Stau2 complexes within cells. The big 
advantage of this approach, however, is that complexes from rat brain display the functions 
of Stau2 in vivo. 
Cultured rat hippocampal neurons are considered to be a suitable in vitro system for 
studying neuronal processes. But since the amount of starting material needed for 
biochemical experiments is exceeding the possibilities of cell culture, cultured neurons are 
rather used for subsequent validation of the findings from rat brain. 
 
In general, during this thesis, differences were found between results from E17 and adult rat 
brain, suggesting a varying protein composition of RNPs dependent on the developmental 
stage. This led to the hypothesis that Stau2 might have different functions through the life 
span of an organism. Since more protein-interactors for Stau2 were found for E17 rat brain, 
these differences could also result from a lower IP efficiency in the adult brain. Therefore, 
low abundant Stau2 interactors are less likely to be found. Optimization of the IP protocol 
from adult rat brain is needed before definite conclusions can be drawn. 
In more detail, the results from the candidate protein search showed that Stau2 interacts 
with Upf1 in an RNA-dependent manner. This interaction was of high reliability, therefore it 
was used as a marker for successful IPs. Upf1 is an RNA helicase, involved in nonsense-
mediated decay (NMD). Upf1 was further shown to interact directly with Stau1, which can 
recruit the helicase to the 3’-UTR of ADP-ribosylation factor (Arf)1 and other mRNAs to elicit 
exon-junction complex (EJC)-independent mRNA decay (Kim et al. 2005; Kim et al. 2007). 
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The interaction of Upf1 with Stau2 could be of similar kind as for Stau1, being necessary for 
degradation of mRNAs no longer needed e.g. at the synapse.  
4.1.1 STAU2 IS ASSOCIATED WITH RIBOSOMES 
Previously, a connection between Stau and ribosomes has been found (Duchaine et al. 2002; 
Mallardo et al. 2003). Duchaine at al. reported co-sedimentation of Stau2 with ribosomal 
markers (L7a) and co-fractionation with 40S and 60S ribosomal subunits even after EDTA 
treatment, which disrupts assembled ribosomes. The group was able to co-precipitate Stau2 
with a human anti-ribosomal protein antiserum. For Stau1, a co-fractionation as well as 
direct interaction with ribosomal protein P0 (which is an indicator for the 80S ribosome) was 
shown (Brendel et al. 2004). Furthermore, the interaction of Stau1 with ribosomes was 
mapped to the RBD3, the main dsRBD (Luo et al. 2002).  
I extended those findings now by proving a direct protein-protein interaction of Stau2 with 
two ribosomal proteins, L7a and S6 in E17 rat brains suggesting that Stau2 may bind to the 
ribosome. Further support for this interaction comes from the presence of rRNAs in Stau2 
complexes, namely 28S and 18S but also 5S and 5.8S rRNAs as shown in this thesis. 
However, the absence of eIF4E and eEF1α, factors involved in initiation and elongation of 
translation, in IPs from E17 and adult rat brain supports the idea that mRNAs in Stau2 
complexes are not actively translated despite the presence of ribosomes. Consistent with 
these findings, it was shown that association of Stau2 with ribosomes is independent of 
translation (Duchaine et al. 2002). 
 
The functional relevance for association of Stau2 with ribosomes remains to be investigated. 
As postulated by Krichevsky and Kosik, synaptic stimulation may cause a local release of 
mRNA and translational components (including ribosomes) from granules at the synapse 
linking RNA localization to translation (Krichevsky and Kosik 2001). Thus, a possible reason 
for association of Stau2 with ribosomes could simply be localizing ribosomes for immediate 
translation of mRNAs at their destination site. 
Other means by which ribosomes can play a role in Stau2 complexes originate from the 
finding that the dsRBD5 of Stau2 was involved in activating the translation of oskar mRNA in 
D. melanogaster (Micklem et al. 2000). Since the RBD5 is not able to bind RNA, the effect on 
translational activation is very likely mediated via protein interaction with Stau2. One could 
speculate that ribosomal proteins may play a role in this regulation. 
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4.1.2 RISC PROTEINS IN STAU2 COMPLEXES 
Furthermore, using the candidate protein search, I found evidence that Stau2 complexes 
contain molecules involved in silencing mRNAs. IP experiments proved the RNA-dependent 
interaction of Stau2 with Ago and PACT in E17 rat brain. Ago and PACT are proteins known 
to be associated with the RISC (Peters and Meister 2007; Lee et al. 2006). Additional support 
for this hypothesis came from the finding that FMRP and eIF6 also represent interactors of 
Stau2 complexes in E17 rat brain and for eIF6 also in adult rat brain. eIF6 and FMRP were 
postulated to be associated with the RISC and have repressive functions on mRNA 
translation (Chendrimada et al. 2007; Jin et al. 2004). Taken together, these findings are 
consistent with the idea of mRNAs being repressed in Stau2 complexes and not actively 
translated. Thus, FMRP and eIF6 could contribute to silencing of mRNAs in Stau2 complexes. 
Since all four proteins are part of miRNPs/RISC, the silencing could be a result of RISC 
recruitment to the particles.  
The presence of different RISC-associated components, Ago, PACT, FMRP and eIF6 in Stau2 
complexes suggests a participation of the miRNA pathway. The relevance of these findings is 
versatile. On the one hand, as mentioned above, the need for silencing mRNAs in Stau2 
complexes could lead to recruitment of RISC from the cytoplasma to Stau2 complexes. On 
the other hand, one could propose exchange of mRNA or other components between Stau2-
containing RNPs and P-bodies, which are known to contain RISC components (Wu and 
Belasco 2008). This hypothesis was derived from the finding of transient “docking” events 
between Stau2 and Dcp1-containing particles, observed by time-lapse videomicroscopy 
(Zeitelhofer et al. 2008, in press). These “docking” events could build the basis for exchange 
of components, leading to a hypothesis of a very complex interplay between different 
particles. 
4.2 RNA COMPOSITION OF STAU2 COMPLEXES 
4.2.1 MIRNAS ARE ASSOCIATED WITH STAU2 COMPLEXES 
Additional evidence supporting the involvement of miRNAs in Stau2 complexes was provided 
by RNA labeling experiments. I observed a specific association of small RNAs between 50 
and 20 nt with Stau2 complexes in E17 rat brain, especially a prominent band at ~22 nt, 
which refers to mature miRNAs. Using the high-speed centrifugation supernatant (S100) as 
input for the IP, I detected a double-band at 20/22 nt, which is very characteristic for 
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miRNAs. Specific amplification of candidate miRNAs, miR-18, 26a, 128a, 134 and let-7c, by 
RT-PCR proved unequivocally the presence of mature miRNAs in Stau2 complexes. For adult 
rat brain, no distinct bands for miRNAs could be visualized during labeling experiments due 
to a high background signal. However, RT-PCR successfully proved the association of 
miR-26a, 128a and let-7c with Stau2 complexes. miR-18 was expressed only at very low 
levels in adult rat brain and for miR-134 problems with primer-dimers arose. The identity of 
other small RNAs of higher size (30 – 50 nt) detected in Stau2 complexes by labeling 
experiments is still unclear. Subsequent cloning approaches will clarify their origin. 
 
The fact that miRNAs interact with Stau2 complexes raises different hypotheses concerning 
the biological relevance. First, miRNAs could function in silencing of mRNA present in Stau2 
complexes. It was shown that Stau1-containing RNPs move along microtubules from the cell 
body into dendrites, suggesting a functional role of Staufen proteins in the dendritic 
localization of mRNAs (Köhrmann et al. 1999). Assuming that Stau2 plays a role in mRNA 
transport too, miRNAs provide one possibility of repressing translation during this process. 
Up to now there is only one published example, showing that miRNAs can play a crucial role 
in silencing mRNAs at the synapse. Namely, the translation of Limk1, a localized mRNA, 
which was shown to be affected by miR-134 (Schratt et al. 2006).  
The fact that 5 out of 5 tested candidate miRNAs were present in Stau2 complexes was 
surprising at first glance. However, preliminary microarray data of the mRNA composition of 
Stau2 particles in E17 rat brain (A. Konecna, M. Bilban and M. Kiebler, unpublished) yielded 
more than 2000 different mRNAs. Provided that one particular mRNA may be regulated by 
different miRNAs, I expect several miRNAs to be present in Stau2 complexes. Combining 
these two findings, the significance of miRNAs in silencing mRNAs in RNPs might have been 
underestimated so far. 
With a closer look at those 5 tested miRNAs, more detailed hypotheses are possible. Using 
PicTar (provided by the Rajewsky lab), β-actin mRNA was the only predicted target for 
miR-18. First, this mRNA was found to undergo Stau2-dependent regulation (Goetze et al. 
2006; Y. Xi, P. Macchi and M. Kiebler, unpublished) and second, its presence in Stau2-
containing complexes was shown (D.Karra, 2008, PhD thesis). Furthermore, actin plays a 
crucial role in formation and migration of neurites and the growth cone (Yao et al. 2006; 
Leung et al. 2006). Therefore, the presence of miR-18 in E17 Stau2 complexes leads to the 
assumption that translation of β-actin mRNA in Stau2 particles could be silenced by miR-18. 
miR-26a, 128a, 134 and let-7c were found in dendrites using a laser-capture based multiplex 
RT-PCR approach (Kye et al. 2007). In addition, miR-134 was shown to target Limk1 and 
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miR-26a to target MAP2, respectively (Schratt et al. 2006; Kye et al. 2007). The presence of 
these two mRNAs in Stau2 granules (A. Konecna and M. Kiebler, unpublished; D. Karra, 
2008, PhD thesis) yields two more possible pairs of mRNA-miRNA duplexes in Stau2 
complexes. miR-128a, enriched in adult rat brain (Kim et al. 2004), was amplified from both 
developmental stages; the same was true for let-7c. Predicted targets for these miRNAs 
were of notable diversity. Therefore, no conclusions about possible pairs could be drawn at 
this stage. Still, for all miRNAs found in Stau2 complexes additional validation experiments 
are necessary, which are discussed in the future perspectives. 
 
The fact that ribosomes are part of Stau2 complexes does not contradict the association with 
miRNAs. First, mRNAs are thought to be silenced within particles (Dahm and Kiebler 2005). 
Second, evidence was found that miRNAs co-purify with polysomes in a human neuronal cell 
line (Nelson et al. 2004) and in mammalian neurons (Kim et al. 2004). A model can be 
envisioned where mRNAs, miRNAs, ribosomes and Stau2 are present in one complex: The 
mRNA, covered by ribosomes, is silenced by a miRNA bound to its 3’-UTR. Stau2 associates 
either via direct binding to the ribosome or also to the 3’-UTR of the mRNA. 
4.2.2 MIRNAS IN DIFFERENT STAU2 COMPLEXES 
Previous gel filtration experiments in the lab allowed to distinguish distinct pools of Stau2- 
containing particles in adult rat brain: high molecular weight granules (above 2 MD) and 
smaller 700-400 kD particles (Mallardo et al. 2003); as well as smaller complexes of 200 kD, 
(A. Konecna and M. Kiebler, unpublished). Therefore, it was of great interest, in which 
Stau2-containing complexes miRNAs are present. Recently, miRNPs were shown to be rather 
small complexes of ~200 kD that differ from siRNA complexes (Gu et al. 2007). 
I therefore performed gel filtration experiments, which aimed at separation of Stau2-
containing complexes of different sizes and monitoring the association of miRNAs within 
these complexes. Results for E17 rat brain suggested that in low molecular weight 
complexes, Stau2 might be associated with miRNAs and components of the RISC. For adult 
rat brain, Stau2 co-fractionation with Ago and PACT in low molecular weight complexes was 
found too. However, at the RNA level, detection of miRNAs was not possible due to a high 
background. The main difference between the results of E17 and adult rat brain was the 
estimated size of these low molecular weight particles: 200 kD for adult, which corresponds 
to the results from Gu et al. 2007; but just 60 kD for E17. The small size of 60 kD would 
contradict the existence of particles, but rather suggests monomers. Clearly, these 
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differences between E17 and adult RISC and miRNA co-fractionating Stau2 complexes have 
to be further investigated before definite conclusions can be drawn. 
4.2.3 STAU2 AND EXPORT OF PRE-MIRNAS 
Stau2 was shown to be transported by the same export factor Exportin-5 which is involved in 
pre-miRNA export from the nucleus (Macchi et al. 2004). Since Stau2 interacts with stem-
loop structures containing 12 uninterrupted base pairs in vitro (Ramos et al. 2000) and 
pre-miRNAs are folded into hairpin structures these findings are of great interest. In 
addition, Stau2 export was shown to depend on dsRNA mediating the interaction with Exp-5 
(Macchi et al. 2004). Thus, a second function for Stau2 in the miRNA pathway emerges: 
Stau2 may play a role in binding pre-miRNAs and facilitating their export. However, direct 
evidence for pre-miRNAs in Stau2 complexes is still missing. First, the RT-PCR system from 
Ambion is designed to amplify mature miRNAs only. Second, the detection of RNAs at 70 nt 
in size by radioactive labeling can only indirectly refer to pre-miRNAs and might also be 
overlaid by the signal of tRNAs of the same size (70-90 nt). Thus, pre-miRNA detection by 
Northern blotting or RT-PCR is an immediate goal that is discussed below in the future 
perspectives.  
4.3 FUTURE PERSPECTIVES 
Since the association of Stau2 complexes with miRNAs was shown for some candidates, the 
immediate question to be asked is: How many and which miRNAs are present in Stau2 
complexes? Therefore, I would like to obtain a detailed list of all interacting miRNAs in E17 
or adult rat brain by cloning miRNAs from Stau2 IPs followed by subsequent sequencing. The 
obtained list of miRNAs will then allow us to compare them to microarray data for mRNAs 
(A. Konecna and M. Kiebler, unpublished) using a bioinformatics approach. Finally, detailed 
knowledge about the composition of RNAs in Stau2 complexes will result in the identification 
of additional mRNA-miRNA pairs in the near future. 
Furthermore, I expect that the cloning approach will shed some light on the origin of other 
small RNAs of bigger size (30-50 nt) that were specifically found in the Stau2 complexes.  
 
Validation of the interacting miRNAs found in those experiments will be important since the 
possibility of post-lysis interactions cannot be excluded (Mali and Steitz 2004). Such 
validation experiments can be carried out in cultured rat hippocampal neurons. First, in situ 
hybridization for miRNAs using locked nucleic acid (LNA) probes can answer the question if 
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these miRNAs are expressed and especially how they are distributed in neurons. Subsequent 
co-staining in neurons for Stau2 and miRNAs of interest can validate their association.  
Furthermore, it will be important to investigate the presumable role of Stau2 in the export of 
pre-miRNAs. This can be achieved by Northern blotting, where, according to the size of the 
signal, mature, pri- and pre-miRNAs can be distinguished. As a second approach, RT-PCR 
with primers specific for pre-miRNA but not mature miRNAs could further clarify the 
association of Stau2 with pre-miRNAs. 
 
One of the main questions left is in which RNPs Stau2 and miRNAs associate. To follow up 
on the preliminary results from the gel filtration experiments, these should be repeated to 
confirm the differences in size of small, RISC co-fractionating, Stau2 particles between E17 
and adult. IP experiments need to be performed from a pool of large versus small Stau2 
complexes from both developmental stages to investigate differences in protein composition. 
In case gel filtration experiments are not successful, attention can also be put on using 
density gradients for separating Stau2 particles of different sizes as done before (Mallardo et 
al. 2003). 
 
Overall, the presence of miRNAs in Stau2 complexes from E17 and adult rat brain was shown 
within this thesis. A very interesting question left is the biological function of Stau2 in the 
miRNA pathway, which for sure will turn into a promising but also challenging project.
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6 APPENDIX 
6.1 ABBREVIATIONS 
Ago  Argonaute 
amp  Ampicillin 
APS  Ammonium peroxodisulfate  
ATP  Adenosine triphosphate 
BDNF  brain derived neurotrophic factor 
bp  base pairs 
BSA  Bovine serum albumin 
CaMKIIα calcium/calmodulin-dependent protein kinase IIα 
cDNA  complementary DNA 
CT  C-terminal 
DEPC   Diethyl pyrocarbonate 
DMP  Dimethyl pimelimidate 
DMSO  Dimethyl sulfoxide 
DNA  desoxyribonucleic acid 
DOC  Deoxycholate 
dsRBD  double stranded RNA-binding domain 
DTT  Dithiothreitol 
E17  embryonic day 17 
EDTA  Ethylenediaminetetraacetic acid 
eEF  eukaryotic elongation factor 
eIF  eukaryotic initiation factor 
EtBr  Ethidium bromide 
FL  full length  
FMRP  fragile X mental retardation protein 
FT  flow-through 
g   gravity (or grams for chemicals) 
GF  gel filtration 
GSFF  Glutathione SepharoseTM 4 Fast Flow 
GST  Glutathione-S-transferase 
h  hour/hours 
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HEPES  2-[4-(2-Hydroxyethyl)-1-piperazinyl-ethanesulfonic acid 
IP  immunoprecipitation 
IPTG  Isopropylthiogalactopyranoside 
kb  kilo basepairs 
kD   kilo Dalton 
Limk1  LIM domain kinase 1 
MAP  microtubulin associated protein 
MCS  multiple cloning site 
mA  milli amperes 
min   minutes 
mRNA  messenger RNA 
miRNA  micro RNA 
MOPS  Morpholinopropane sulfonic acid 
MW  molecular weight marker 
NP-40  Nonidet™ P 40 Substitute 
nt  nucleotides 
NTC  non template control 
OD  optical density 
o/n  overnight 
PACT  protein activator of the interferon-induced protein kinase PKR 
PAGE  Polyacrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
pCp  Cytidine 3',5'-bis [α-32P] phosphate 
PCR   polymerase chain reaction 
pDNA  plasmid DNA 
PIS   preimmune serum 
PNS  post nuclear supernatant 
ProtA  Protein A Sepharose 
RBD   RNA-binding domain 
RBP  RNA-binding protein 
RISC  RNA induced silencing complex 
RNA  ribonucleic acid 
RNase  ribonuclease 
RNP  ribonuclearprotein particles  
rpm  rounds per minute 
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rRNA  ribosomal RNA 
RT  room temperature or reverse transcription 
S   Svedberg 
S100  supernatant after centrifugation at 120,000 g 
SDS  Sodium dodecylsulfate 
sec  seconds 
siRNA  small interfering RNA 
Stau  Staufen 
TBD   tubulin binding domain 
TBS  Tris buffered saline 
TCA  Trichloric acid 
TEMED N,N,N’,N’-Tetramethylethylenediamine 
TRBP  human immunodeficiency virus (HIV-1) trans-activating response (TAR) RBP 
tRNAs  transfer RNAs 
u   enzymatic units 
Upf1  Upregulated protein factor 1 
UTR  untranslated region 
V  volts 
WB  Western blot 
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